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ABSTRACT
Histoplasma capsulatum (Hc) is a systemic, dimorphic fungal pathogen that
affects upwards of 500,000 individuals in the United States annually. Hc grows as a
multicellular mold at environmental temperatures; whereas, upon inhalation into a human
or other mammalian host, it transforms into a unicellular, pathogenic yeast. The research
presented in this dissertation is focused on characterizing the DNA damage-responsive
gene HcDDR48. HcDDR48 was originally isolated via a subtractive DNA library
enriched for transcripts enriched in the mold-phase of Hc growth. Upon further analysis
we found that HcDDR48 is not just expressed in the mold morphotype, but both growth
programs dependent upon the environment. Since the yeast phase of Hc is the phase that
interacts with the host, the research in this dissertation focused solely on HcDDR48’s
involvement in yeast-phase Hc. We found that HcDDR48 is involved in oxidative stress
response, antifungal drug response, and survival within resting and activated
macrophages. Growth of ddr48 yeasts was severely decreased when exposed to the
reactive oxygen species generator paraquat, as compared to wildtype controls. We also
found that ddr48 yeasts were 2-times more sensitive to the antifungal drugs
amphotericin b and ketoconazole. To test HcDDR48’s involvement in vivo, we infected
resting and activated RAW 264.7 murine macrophages with Hc yeasts and measured
yeast survival 24-hours post-infection. We observed a significant decrease in yeast
recovery in the ddr48 strain compared to wildtype Hc levels. Herein, we demonstrate
the importance of maintaining a functional copy of HcDDR48 in order for Hc yeasts to
sense and response to numerous environmental and host-associated stressors.
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CHAPTER I – INTRODUCTION AND LITERATURE REVIEW
1.1 Introduction
Histoplasma capsulatum (Hc) is the etiological agent of histoplasmosis, one of the
leading endemic mycoses in the world. It is a thermally dimorphic fungus, meaning its
lifecycle exists in two distinct, temperature-dependent, forms (1). At environmental
temperatures (25C) the fungus grows as a multicellular, saprophytic mold that produces
vegetative microconidia and macroconidia. When soil contaminated with Histoplasma
conidia is disturbed, the conidia are aerosolized where they are potentially inhaled into a
human or other mammalian host’s lungs. The increase in temperature (37C) within the
host’s lungs triggers a transcriptional growth program in Histoplasma that promotes a
dimorphic shift to unicellular, pathogenic yeasts (1–3). The dimorphic shift from mold to
yeast is critical for Histoplasma pathogenesis, as locking Hc in its filamentous form
inhibits colonization of mice in a murine model of Histoplasmosis (4–6). H. capsulatum
is distributed world-wide, but is primarily endemic to the continents of North America,
Central America, and Africa (7). In the United States, H. capsulatum is found primarily
in the Mississippi and Ohio River valley regions, where it is found closely associated
with soils enriched with bird or bat guano (2, 8, 9). In these endemic areas, serological
data indicates that roughly 80% of the population has been exposed to H. capsulatum,
with over 500,000 new cases of histoplasmosis diagnosed each year in the United States
(10). H. capsulatum is a primary fungal pathogen, meaning it causes disease in both
immunocompetent and immunocompromised hosts, which sets it apart from other
endemic fungal pathogens (11). Histoplasmosis is usually a self-limiting disease;
however, immunocompromised individuals can develop a more severe form of
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histoplasmosis where Histoplasma disseminates to other organs like the liver, kidneys, or
spleen (12). A unique feature of Hc is its ability to become an intracellular pathogen of
phagocytes, thus shielding it from the host immune system and also providing an
uninhibited vehicle for dissemination. H. capsulatum yeasts produces several virulence
factors to evade killing and establish its niche within phagocytic cells (13–20). In the
pathogenic, dimorphic fungus Candida albicans, the stress response protein DDR48 is
highly expressed during in vivo infections and is also required for detoxification of
reactive oxygen species (21–24). DDR48 is considered an “immunogenic” protein in
Candida albicans, suggesting a role in virulence (25). Based on these observations, we
asked if DDR48 is involved in pathogenesis in H. capsulatum. Our preliminary studies
have shown that DDR48 is required for resistance to reactive oxygen species and DNAdamaging agents. We have also demonstrated, through a ddr48-deletion strain, that
DDR48 is required for proper oxidative stress response in Histoplasma yeasts. These
findings suggest that DDR48 is a good candidate to investigate as a member of the
intricate virulence cascade of H. capsulatum. The central focus of this dissertation
research is to characterize Histoplasma DDR48 and determine if it is contributing to
Histoplasma pathogenesis.
1.2 Histoplasma capsulatum Pathogenesis
Once in the host’s lungs, H. capsulatum promotes phagocytosis while minimizing
innate immune stimulation. The innate immune response is insufficient to eliminate
Histoplasma infections. While Hc does not elicit a robust immune response, the fungal
pathogen does interact with a variety of immune cells, including macrophages, dendritic
cells, and neutrophils, within the host, which evolves over the course of the infection (26,
2

27). Most fungal pathogens avoid phagocytosis and have developed intricate ways to do
so. The dimorphic fungus Cryptococcus neoformans contains a thick, polysaccharide
capsule to prevent phagocytosis as well as secretion of antiphagocytic proteins (28–30).
Moreover, when phagocytized, C. neoformans induces exocytosis to escape from
phagocytes in a non-lytic manner (31). Candida albicans, another fungal pathogen,
transitions from unicellular yeasts to filamentous psudohyphae upon phagocytosis, which
promotes lysis of the phagocyte and subsequent release C. albicans in a lytic manner
(32–34). The mechanisms employed by these pathogenic fungi to avoid or escape
phagocytosis suggests that the intracellular lifestyle is not favorable for most fungal
pathogens. Interestingly, Histoplasma promotes phagocytosis and has evolved to be a
predominantly intracellular pathogen of phagocytes (35). The intracellular niche within
phagocytes provides H. capsulatum with an environment within the host that is beyond
the reach of the innate immune system. This unique feature of H. capsulatum is
paramount in promoting extrapulmonary dissemination throughout the host, leading to
the more severe systemic form of histoplasmosis. Newman, et. al showed that after 1
hour of exposure to Hc cells, alveolar macrophages ingested an average of 120 Hc yeasts
or 70 Hc conidia per 100 macrophages (36). As a result, Hc cells are rarely observed
outside of phagocytes over the course of infection (27).
1.3 Interactions With The Innate And Adaptive Immune System
Once Histoplasma capsulatum (Hc) conidia are inhaled into a host’s lungs, the
increase in temperature promotes a dimorphic shift from mold spores to unicellular,
pathogenic yeasts. Histoplasma yeasts travel down the bronchi and bronchioles until they
reach the terminal alveoli of the lungs. Alveolar macrophages, part of the innate immune
3

system, reside in the alveoli to monitor and eliminate any foreign materials (biological or
non-biological) that were not removed via the mucociliary escalator. While most
pathogens attempt to avoid detection by the host’s innate immune system, Hc stimulates
host macrophages to readily phagocytize them. Hc has evolved the ability to fine-tune the
phagocytic process to balance successful phagocytosis without overstimulation of
immune receptors on host phagocytes.
All phagocytic cells will respond to Histoplasma; however, macrophages,
dendritic cells, and neutrophils each interact and respond differently. This is indicative
that each of the cell types possess unique roles during the innate immune response.
Dendritic cells rapidly recognize and eliminate Histoplasma yeasts after phagocytosis;
however, macrophages cannot eliminate Histoplasma yeasts unless they are activated by
the cytokines IFN (interferon-gamma), TNF (tumor necrosis factor-alpha), or GM-CSF
(granulocyte-monocyte colony stimulating factor). Therefore, macrophages can only
control a Histoplasma infection with a CD4 T-cell (Th1) cytokine activation (37, 38).
In the early stages of infection, alveolar macrophages recognize H. capsulatum
yeasts and conidia via adhesion proteins LFA-1 (CD11a/CD18), complement receptor 3
(CR3) (CD11b/CD18), and CR4 (CD11c/CD18), which belong to the CD11/CD18 family
of integrins and initiate phagocytosis of the fungal pathogen (27, 36, 39). The H.
capsulatum ligand that binds to CD18 family receptors and thus facilitates phagocytic
uptake is a 60 kDa heat shock protein, HcHSP60 (40). While HcHSP60 is predominantly
found in the cytoplasm functioning as an intracellular chaperone protein, a subpopulation
of HcHSP60 localizes to the fungal cell surface (40, 41). Un-activated macrophages are
unable to control Hc growth, which eventually results in death of the macrophage and
4

sequential release of Hc yeasts into the interstitium. Macrophages release the
proinflammatory cytokines TNF, IL-1, IL-6, and CCL-2 in response to infection by
Histoplasma cells. Once macrophages are activated, they increase production of nitric
oxide (NO), reactive oxygen species (ROS), and increase intracellular sequestration of
nutrients such as essential divalent cations (e.g. iron and zinc). These physiological
changes, coined nutritional immunity, serve to restrict and eliminate the engulfed Hc
yeasts (42–44). Un-activated macrophages allow Histoplasma yeasts to replicate and
survive within the phagosomal compartment unimpeded, where phagosome-lysosome
fusion is either inhibited or Hc yeasts are able to resist the changes in pH associated with
such fusion. There are conflicting reports in the literature regarding the phagosomelysosome fusion, which suggests that more research needs to be completed and/or fusion
is dependent on the cell type (45).
Dendritic cells also recognize Hc cells and phagocytose them via the very-late
antigen 5 (VLA-5) receptor interaction with the Hc protein cyclophilin A (CypA) (38,
46). Dendritic cells can rapidly degrade Hc cells without the need for proinflammatory
stimuli. This is due to the fact that dendritic cells are proficient in presenting antigens and
thus proficient in eliciting T-cell activation of the proinflammatory cytokine cascade
when compared to macrophages (38, 47). The host’s physiological response to
phagocytizing H. capsulatum cells is to fuse the phagosome containing the fungal
pathogen with lysosomes, forming a phagolysosome, which serves to acidify the vacuole
and promote killing of the engulfed invaders. Dendritic cells do successfully fuse the
phagosome and lysosome, yielding a phagolysosome to control Hc fungal burden (48).
Dendritic cells also serve to propagate the innate immune response to Hc infection since
5

they are professional antigen presenting cells (APCs) that present antigens recovered
from Hc yeasts that interact with Th1 cells and promote the inflammatory response (38).
Neutrophils interact with Hc cells during the innate immune response by
localizing to the site of infection early on during Hc infection of the host lungs (49).
Studies have shown that Hc cells can be found within the cytoplasm of neutrophils;
however, the way in which neutrophils respond to Hc cells is unclear. It is known that
neutrophils undergo respiratory burst, releasing reactive oxygen species (ROS) in
response to interaction with Hc cells, which exerts fungicidal activity (20). The early
arrival and response of host neutrophils is pivotal in delaying Hc infection until adequate
stimulation and activation of the adaptive immune system can be achieved.
Another way the innate immune response participates in an Hc infection is by
surveillance using pattern recognition receptors (PRRs), which when activated, stimulate
an immune response. Hc cells can be recognized by both toll-like receptors (TLRs) and
C-type lectin receptors. When TLR2 recognizes the Yps3 on Hc yeasts, generation of the
proinflammatory molecule leukotriene B4 is induced, in a MyD-88-dependent manner,
which aids in host control of histoplasmosis infection (50). When dendritic cells carrying
TLR7 and TLR9 come into contact with Hc cells the host mounts a type 1 interferon
response, which aids in elimination of histoplasmosis infection (51). The host utilizes the
C-type lectin receptors Dectin-1, Dectin-2, and Mincle for recognition of beta-glucan
polysaccharides on the surface of Hc cells, where recognition of Hc by these receptors
leads to an increase in IL-1 family cytokines (52, 53). Upon recognition of Hc by Dectin2 receptors, the host activates the NLRP3-inflammasome, which in turn releases activated
IL-1 (53). These processes all serve to stimulate the innate immune system and aid in
6

clearance of Hc cells. While infection with other fungal pathogens almost always results
in a robust innate immune response.
1.4 Histoplasma Virulence Factors
As mentioned above, Histoplasma capsulatum is predominantly an intracellular
pathogen of phagocytes. To avoid recognition by the innate immune mechanisms
mentioned above, H. capsulatum has evolved intricate molecular mechanisms to avoid
recognition and killing. As soon as H. capsulatum reaches the alveoli in the host’s lungs,
it is challenged with surfactants, like surfactant proteins A and D (SP-A and SP-D), that
serve as the first line of defense employed by the host against foreign invaders (54). SP-A
and SP-D are considered pulmonary collectins, which contain a C-type lectin domain,
enabling binding of these surfactant proteins to the polysaccharides present on fungal cell
walls (55). SP-A and SP-D possess anti-Histoplasma activity by causing permeabilization
of H. capsulatum yeast cells (56). Most Histoplasma cells are quickly phagocytized and
thus protected from the extracellular surfactants.
Since H. capsulatum yeasts must come into close contact with the surface of
phagocytes in order to gain entry, there is risk of stimulating pattern recognition receptors
on the phagocyte surface and thus elicit an immune response. The success of H.
capsulatum pathogenesis relies on minimizing contact with these surface receptors while
simultaneously triggering phagocytosis. The most common surface receptors that
recognize fungal pathogens include Toll-like receptors (TLRs) and C-type lectin
receptors, as mentioned above (55). These receptors contain polysaccharide recognition
domains that are capable of recognizing -glucans present on the fungal cell surface.
Dectin-1, a C-type lectin, is the primary receptor for detecting fungal -glucans (57).
7

When -glucans on the fungal cell wall are bound to Dectin-1, an inflammatory response
is initiated that leads to the production of reactive oxygen species (ROS) and
proinflammatory cytokines by the phagocyte (58–61). To decrease contact with Dectin-1,
H. capsulatum yeasts surround their -glucans with -linked glucans, which are noninflammatory and significantly reduce recognition of H. capsulatum yeasts by Dectin-1
(62). -glucans are synthesized by an endogenous -(1,3)-glycan synthase, HcAGS1,
from short glucans formed by the -amylase enzyme HcAMY1 (17, 63). Without
HcAGS1 and HcAMY1, H. capsulatum yeasts are unable to produce -glucans, resulting
in severe attenuation of H. capsulatum virulence in vivo (17).
Hc yeasts must be able to cope with the nutrient limitations that are mounted by
the host within the phagosome. Host immune cells sequester essential metals like zinc
and iron to deprive the pathogen and thus decrease pathogen survival; however,
pathogens have developed intricate mechanisms to acquire essential metals and other
nutrients from the host. Hc yeasts can obtain iron from transferrin and ferritin or utilize
siderophores for iron acquisition, as Hc yeasts that lack the siderophore biosynthesis
enzyme HcSID1 are unable to grow in iron-limited conditions in vitro and show severely
reduced fungal burdens in vivo (64, 65). Regulation of iron utilization in Hc is achieved
by the GATA transcription factor HcSRE1, which represses expression of siderophore
biosynthesis genes. Silencing of HcSRE1 by RNA-interference determined that HcSRE1
regulates roughly 36 iron-responsive genes, which all contain a consensus sequence
upstream of their start site where HcSRE1 binds (66). The gamma-glutamyltransferase
enzyme, HcGGT1, encodes a 320 kDa protein complex that acts as a ferric reductase in
vivo over a wide range of pH’s, but is also capable of reducing iron from transferrin and
8

hydroxamate siderophores (67). The vacuolar ATPase HcVMA1 is also required for
survival in iron depleted conditions as a HcVMA1 mutant was unable to grow in iron
depleted growth medium, replicate in human macrophages, or colonize murine lungs and
spleens (68, 69).
The calcium binding protein HcCBP1 is a secreted protein found in yeast-phase
H. capsulatum. HcCBP1 was originally characterized in experiments to determine how
H. capsulatum yeasts were able to survive in calcium-limiting growth conditions, and
was the first secreted virulence factor identified in H. capsulatum (70). While the exact
mechanisms of how HcCBP1 aids in pathogenesis is unknown at this time, deletion of
HcCBP1 markedly decreases intracellular H. capsulatum survival and leads to
attenuation in its ability to colonize the lung (71). The function of HcCBP1 is proposed to
be predominantly within the macrophage phagolysosome where is can bind two
molecules of calcium (Kd = 6 nM) (72). HcCBP1’s affinity for calcium binding provides
evidence that this protein is responsible for H. capsulatum calcium acquisition in the
phagolysosome, where nutrients are sequestered by the host and in limited amounts. Beck
et al. found that HcCBP1 contains three disulfide bonds, making it a very stable protein
that is resistant to proteolysis and denaturation over a wide range of pH values, which
promotes H. capsulatum survival in the acidic phagolysosome (73).
Once in the phagosome, Histoplasma yeasts deter killing by utilizing various
virulence factors to combat the stressors presented by the macrophage. The macrophage
recruits the NADPH oxidase complex to the phagosome membrane, which generates
reactive oxygen species (ROS) in the form of superoxide anions to eliminate the engulfed
pathogen (74). The production of ROS by the macrophage is an essential mechanism of
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the innate immune system to effectively eliminate Histoplasma yeasts (75). The
superoxides and their derivatives directly damage Hc cells by lipid peroxidation, DNA
damage, and dysregulation of enzymatic pathways. Most organisms possess molecular
machinery to cope with intracellular ROS that are generated by aerobic respiration;
however, ROS derived from macrophages are extracellular and thus cannot be eliminated
by intracellular enzymes. Histoplasma yeasts express extracellular ROS defensive
enzymes to deal with the macrophage-derived ROS (76). One of the extracellular
detoxification enzymes is the superoxide dismutase HcSOD3. HcSOD3 was identified in
Hc by mass spectrometry of the culture lysate, where the investigators were searching for
secreted proteins produced by Hc yeasts. They have shown that HcSOD3 is an
extracellular, copper-dependent superoxide dismutase, which fits with its function to
detoxify host-derived ROS. They also found that Hc yeasts lacking a functional copy of
HcSOD3 were unable to successfully colonize a murine host and were quickly eliminated
by innate defenses (77). Furthermore, when Hc yeasts that were deficient in HcSOD3
were introduced into mice lacking the NADPH oxidase system, Hc survival was equal to
that of wild-type, HcSOD3-expressing yeasts (77). Hydrogen peroxide is liberated from
SOD-dependent breakdown of superoxide species; therefore, H. capsulatum also contains
extracellular catalases to effectively neutralize hydrogen peroxide. H. capsulatum
contains three catalase genes, HcCATB, HcCATP, and HcCATA (78). HcCATB is the
predominant extracellular catalase to break down host-derived ROS. Interestingly, full
virulence of H. capsulatum can be achieved with only one catalase, as deletion of either
catalases separately yielded no change in virulence; however, double deletion of both
HcCATB and HcCATP resulted in attenuated virulence in vivo (20, 78, 79).
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1.5 Stress Response Protein DDR48
1.5.1 Saccharomyces cerevisiae
DDR48 was originally identified in Saccharomyces cerevisiae in 1990 by Treger
and McEntee while screening for transcripts whose expression was dependent upon
treatments that produced DNA lesions or whose expression was dependent upon
exposure to heat shock stress. While no known protein motifs were uncovered, they did
discover that the DDR48 protein contains multiple repeats of the peptide sequence SerAsn-Asn-X-Asp-Ser-Tyr-Gly, where X is either Asn or Asp. They constructed a strain
devoid of DDR48 expression and found that the mutant strain was more sensitive to
killing by 4-nitroquinoline-1-oxide (4NQO) and heat shock stress. They also found that
the spontaneous mutation rate of reversion was reduced by 6 – 14 fold in the mutant
strain, thus implicating DDR48 in recovery of mutations in S. cerevisiae (24). These
results were never replicated; however, and no lab has since been able to confirm if
DDR48 is involved in spontaneous mutation rate. In 1993, Sheng and Shuster performed
a purification and characterization of the DDR48 protein in S. cerevisiae. They found
DDR48 to be a negatively charged, highly hydrophilic glycoprotein that was mainly
glycosylated by N-linked glycans. Interestingly, they determined that DDR48 was able to
hydrolyze ATP and GRP, with Km values of 0.29 mM and 0.58 mM, respectively. They
also found that DDR48 increased in abundance after treatment of yeasts with ethylmethane sulfonate (EMS; DNA damage) or heat shock stress via western blotting. In their
studies, they performed the same stress treatments looking at DDR48 accumulation in a
RAD52 mutant, where they found that the accumulation of DDR48 after stress was
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dependent upon RAD52 because there was no DDR48 accumulation after treatment of the
RAD52 mutant strain (80).
1.5.2 Candida albicans
In the opportunistic dimorphic fungus Candida albicans, DDR48 was found to be
essential for filamentation, stress response, and antifungal drug resistance. After deleting
just one of the two alleles of DDR48, it was found that the mutant was unable to undergo
filamentation on all hyphal-promoting growth mediums tested, including serum. They
also determined that DDR48 is either haploid insufficient or essential, as they could only
successfully delete one allele; however, a study followed up in 2012 and successfully
constructed a full deletion of both alleles of DDR48, thus negating that DDR48 is haploid
insufficient or essential (81). The DDR48 mutant strain was also more susceptible to
treatment with fluconazole, ketoconazole, voriconazole, caspofungin and itraconazole, as
compared to wildtype controls as determined by E-test. Lastly, they challenged the ddr48
mutant and wildtype yeasts to 50 mM hydrogen peroxide and monitored survival for 2
hours in 0.5 hour intervals. They found that survival of the ddr48 mutant after hydrogen
peroxide challenge was decreased by roughly 50% as compared to wildtype controls (82).
DDR48 is also induced in response to macrophages in C. albicans, as cells exposed to
macrophages led to a 8-fold increase in DDR48 transcripts (83). Hromatka et al.
performed a genomic DNA microarray on C. albicans after exposure to nitric oxides for
10 minutes and found that DDR48 was upregulated by 1.9-fold. This demonstrates that
DDR48 is responsive to reactive nitrogen species (RNS) in C. albicans. They also found
that DDR48 was induced in a mutant strain devoid of nitric oxide dioxygenase (YHB1)
activity (84). Another group found that expression of DDR48 in response to amino acid
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starvation is dependent upon the amino acid biosynthesis transcriptional activator GCN4.
They performed transcriptional profiling under amino acid starvation conditions in
wildtype and a gcn4 mutant strain and found that DDR48 expression was upregulated by
2.1-fold in the gcn4 mutant strain (85). The virulence transcription factor CPH1, which is
involved in the formation of hyphae and psudohyphae has been shown to induce DDR48
expression under hyphal inducing conditions (86). In contrast, in C. albicans strains
devoid of the transcriptional repressors TUP1 or NRG1, DDR48 baseline transcriptional
expression was overexpressed by roughly 15-fold (87). Nantel et al. performed
microarray analyses of C. albicans cells in the presence of fetal bovine serum (FBS) at
hyphal-inducing temperatures (37C) and found that DDR48 expression was upregulated
by 2.9-fold (88). Another group repeated these experiments and also found that DDR48
was upregulated in the presence of FBS as well as Spider’s medium, which promotes
formation of hyphae (83). These results suggest a possible role for DDR48 in
filamentation and virulence; however, when mice were inoculated with C. albicans yeasts
devoid of DDR48 expression they succumbed to infection at the same rate as wildtype
strains (82). Another group recently demonstrated that DDR48 was highly induced in all
phases of C. albicans infection in vivo and isolated DDR48 protein in an extract of cell
wall immunogenic proteins (89). This would suggest that DDR48 is found in the cell wall
in C. albicans, a characteristic unique to C. albicans DDR48. Kusch et al. performed a
Coomassie stain on a 2D gel from a stationary growth phase culture of C. albicans and
found DDR48 to be one of the 50 most highly abundant proteins during stationary growth
phase (90). Banerjee and associates performed a genome-wide steroid response study on
C. albicans and found DDR48 induced by 2-fold 30 minutes after the addition of 1mM
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progesterone to yeast cells. They also demonstrated that DDR48 is among a unique subset
of genes that are induced by the presence of ketoconazole, amphotericin b, and 5fluorocytosine, as well as progesterone (91). Cleary et al. confirmed that DDR48 is
involved in the flocculation response as well as resistance to a variety of cellular
stressors. The DDR48 mutant was more susceptible to 4NQO and amphotericin b
treatment, demonstrating that DDR48 is required for stress response and antifungal drug
resistance in C. albicans (81). Another study performed in 2014 expounded on the
implications of DDR48’s role in antifungal drug resistance. They found that clinical
isolates of C. albicans that were resistant to fluconazole had significantly increased levels
of DDR48 mRNAs than those isolates that were fluconazole-sensitive (22).
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CHAPTER II – MATERIALS AND METHODS
2.1 Fungal Strains And Growth Conditions
The Histoplasma capsulatum clinical isolate G186AR (ATCC 26029) was the
wild-type background strain used in this study. Table 2.1 lists all strains constructed
from WU27, which is a spontaneous smooth phenotype and deletion of the URA) gene
(uracil auxotrophy) strain derived from G186AR, which was a kind gift from William
Goldman at UNC Chapel Hill (92). Yeast and mycelial phase cultures were grown in
Histoplasma macrophage medium (HMM) (10.7 g Nutrient Mixture F-12 Ham (Sigma #
N6760), 18.2 g D-Glucose, 1.0 g L-Glutamic acid, 5.96 g HEPES buffer, and 0.084 g Lcysteine; pH 7.5), a modified tissue culture medium optimized to mimic Histoplasma
growth in vivo (93). All cultures were supplemented with 50 µg/ml Ampicillin (Sigma)
and 100 µg/ml Streptomycin (Sigma) to decrease bacterial contamination, and 100
µg/mL uracil (Sigma) for growth of uracil auxotrophs. Yeast phase cultures were grown
at 37°C in a humidified incubator with 5% CO2 and 95% room air atmosphere, with
shaking at 200 rpm. Mycelial-phase cultures were grown at 25°C in room air with
shaking at 200 rpm. Solid media was prepared with the addition of 0.75% w/v agarose
(Sigma). Briefly, 0.75% w/v agarose (ThermoFisher) was sterilized in half the volume of
deionized water before adding to pre-warmed 2X HMM and pouring plates. Growth of
Histoplasma yeasts was determined by measurement of optical density at 600 nm
(OD600), where all experiments were conducted with yeasts grown to mid/late-log (OD600
= 1.2 – 1.8) phase unless otherwise noted. For measurement of growth kinetics, yeastphase cells were grown to mid/late-log phase then diluted with pre-warmed, pre-aerated,
HMM to a final OD600 = 0.1. Cells were then incubated at 37°C for a duration of 7 days.
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Absorbance measurements (OD600) were taken every 24 hours to quantitate growth. For
experiments involving Histoplasma mold, fresh yeast cultures were passed at a 1:10
dilution into room temperature, pre-aerated HMM, and incubated for 5 – 9 days at 25°C
to promote yeast-to-mold transition. The cultures were then passed two more times at a
1:10 dilution before using in experiments.
Table 2.1
Other
Designation

Straina

Genotype

G186A

Wildtype (ATCC# 26029)

WU27b

ura5

WT; DDR48 (+)

USM10

ura5 ddr48::hph

ddr48

USM13

ura5 ddr48::hph / pLE4 [URA5, DDR48]

ddr48 + DDR48

a
b

all strains were constructed from G186A background strain
“smooth” colony variant and uracil auxotroph of G186A (92)

Table 2.1 Histoplasma capsulatum strains used in this study.
2.2 Complementation Of The ddr48 Mutant
The ddr48 mutant was complemented with a genomic copy of the DDR48 gene
from the wildtype strain WU27 cloned into the expression vector pRPU1, which contains
the URA5 gene as well as telomeric repeats. A PCR was first conducted on wildtype
genomic DNA using gene-specific primers that amplified 0.6 kb of sequence upstream
and downstream of the DDR48 open-reading frame, as to ensure that promoter sequence
and terminator sequence were included. The PCR was performed using standard
conditions, as described below, and separated using gel electrophoresis to ensure that the
correct size product was amplified. Once the identity of the PCR fragment was confirmed
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by gel electrophoresis, the PCR fragment was ligated into the bacterial plasmid pCRIITOPO using the TOPO TA Cloning Kit (Invitrogen) per the manufacturer’s instructions.
The plasmid was then transformed into chemically competent TOP10 E.coli (Invitrogen)
using the manufacturer’s instructions. Cells containing the plasmid with the DDR48 PCR
fragment inserted were then cut with the restriction endonuclease EcoRI, which cuts the
DDR48 insert out of the cloning vector. The reaction was then separated by gel
electrophoresis and the band coinciding with the DDR48 fragment was cut out and
recovered using the ZymoClean Gel DNA Recovery Kit (Zymo Research) per the
manufacturer’s instructions. The recovered fragment was then ligated into the expression
vector pRPU1, which contains telomeric repeats that enable episomal management of the
plasmid in Histoplasma cells using T4 DNA Ligase (NEB Biolabs). The final plasmid
was cut with the endonuclease PacI to linearize and expose the telomeric repeats before
being electroporated into the ddr48 mutant strain. Confirmation of rescued DDR48
expression was done by performing a northern blot and quantitative, real-time PCR
(qRT-PCR) to assess mRNA expression.
2.3 Plasmid Generation and Cloning
2.3.1 Cloning Reactions
PCR products were cloned into TOPO Vector (Invitrogen) using the following
reaction (manufacturer’s recommendation): 4 µl fresh PCR product, 1 µl salt solution and
1 µl TOPO vector. The reaction was gently mixed and incubated at room temperature for
5 minutes. The tubes were then placed on ice and transformed as described below.
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2.3.2 E. Coli Transformations and Selection
Chemically competent E. coli obtained from Invitrogen were used when
transformations were necessary. For non-telomeric transformations One Shot™ TOP10
Chemically Competent E. coli (Invitrogen) cells were used. When transforming a
telomere-containing vector, MAX Efficiency™ Stbl2™ Competent Cells (Invitrogen)
were used to decrease transposition events. Transformation was conducted according to
the manufacturer’s directions. Briefly: one vial of the appropriate chemically competent
E. coli was allowed to thaw on ice. 2 µl of the cloning reaction described above was then
added to the whole vial of One Shot™ TOP10 Chemically Competent cells or 50 µl of
MAX Efficiency™ Stbl2™ Competent Cells respectively, and incubated on ice for 10
minutes. The vial was then heat-shocked for 30 seconds in a pre-warmed 42°C water
bath and immediately placed back on ice. Next, 250 µl of room-temperature S.O.C.
Medium (Invitrogen) was added to the cells. The tubes were then capped, gently agitated
to mix, and incubated on a rotary shaker for 1 hour at 37°C. Once the incubation time
elapsed, the reaction was plated at a high concentration and low concentration
respectively on to two pre-warmed LB plates containing 100 µg/mL ampicillin. The high
concentration was 150 µl transformation reaction; whereas, the low concentration was 50
µl of transformation reaction. The plates were then incubated overnight at 37°C and
colonies were screened for correct insertion.
2.4 Electro-Transformation of H. capsulatum
Histoplasma yeasts were grown up to mid-late exponential phase (OD600 = 1.2 –
1.8). A 5-ml aliquot of Hc yeasts was then recovered by centrifugation at 300 x g for 5
minutes at room temperature. The cells were then washed once with an equal volume of
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electroporation buffer (10% w/v D-mannitol) (EP buffer) and recovered by centrifugation
at 300 x g for 5 minutes. The cell pellet was then re-suspended in 200 l of EP buffer.
Next, the cells were transferred in to a 0.2 cm Gene Pulser Cuvette (BioRad). A total of
10 l containing 100 ng of DNA template were then added to the cuvette and mixed
gently my flicking. The cuvette was then placed into the holder of a Gene Pulser Xcell
(BioRad) and electroporated using the following settings: 750 V, 50 F, and 150 . The
cells were then removed from the cuvette, spread onto HMM plates without
supplemented uracil, and incubated at 37C until colonies appeared.
2.5 Nucleic Acid Extraction
2.5.1 H. capsulatum Lysate Preparation
Histoplasma mold was harvested from a 10-ml aliquot from a 10-day old mycelial
culture by vacuum filtration onto a Whatman, Grade No. 1, 11µm filter paper. Cells were
then washed three times with ice-cold 1X PBS - pH 7.4, and removed with a sterile cell
lifter, a beveled edge spatula used for harvesting cells. Histoplasma yeasts were grown to
exponential phase (OD600 1.2 – 1.8) and a 10-ml aliquot of each was collected via
centrifugation at 500 x g for 5 minutes and re-suspended in an equal volume of ice-cold
1X PBS. Cells were recovered via centrifugation at 500 x g for 5 minutes and resuspended in the respective extraction cocktail as described below.
2.5.2 RNA Extraction
RNA was extracted by breaking cells with glass beads in acid phenol. Yeast or
mycelia were re-suspended in 300 µl of extraction buffer (0.1 M C2H3NaO2, 0.2 M NaCl
- pH 5.0, 0.2% SDS), 300 µl PC (phenol [pH 4.5]:chloroform in a 5:1 ratio), and 200 µl
0.5 mm acid-washed glass beads (BioSpec) in a 2.0 mL screw-top microcentrifuge tube
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supplemented with DNaseI (Invitrogen) and RNase Inhibitor (ThermoFisher). RNAs
were liberated by bead-beating on a MP Fast Prep – 24 vortexer at 4.0 m/s in 20 second
intervals with 1 minute intervals of resting on ice for a total of 4 cycles for yeast and 6 –
8 cycles for mold. Cell lysis was monitored using a phase-contrast microscope to ensure
~80% lysis of Histoplasma cells. The cell debris was pelleted by centrifugation at 12,000
x g for 5 minutes at 4°C. The aqueous phase was recovered and transferred to a new 1.5
mL microcentrifuge tube containing 1 mL of ice-cold 100% v/v ethanol and mixed gently
by inverting the tube three times. The ethanol/RNA mixture was incubated at -80°C
overnight to maximize the precipitated RNA yield. RNA was later recovered by
centrifugation at 12,000 x g for 10 minutes at 4°C. The supernatant was removed and the
RNA pellet allowed to air dry for 5 minutes before re-suspension using 50 l of nucleasefree water or 1X TE buffer. The RNA was then quantified using a Nano Drop
spectrophotometer (Thermo Fisher). RNAs were deemed suitable for downstream
analysis if the ratio of  = 260 nm to  = 280 nm (260/280) measured was between 1.8 –
2.2. The extracts were stored at -80C until ready for use.
2.5.3 DNA Extraction
DNA was extracted by breaking cells with glass beads in neutral phenol. Yeast or
mycelia were re-suspended in 400 µl of extraction buffer (100 mM TRIS - pH 8.0, 10
mM EDTA, 250 mM NaCl), 400 µl PC (phenol [pH 6.6/7.9]:chloroform in a 5:1 ratio),
and 300 µl 0.5 mm acid-washed glass beads in a 2.0 mL screw-top microcentrifuge tube.
Cells were ruptured by bead-beating on a MP Fast Prep – 24 vortexer at 4.0 m/s in 20
second intervals with 1 minute intervals of resting on ice for a total of 4 cycles for yeast
and 6 – 8 cycles for mold. Cell lysis was monitored using a phase-contrast microscope to
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ensure ~80% lysis of Histoplasma cells. The cell debris was pelleted by centrifugation at
12,000 x g for 5 minutes at 4°C. The aqueous phase was recovered and transferred to a
new 1.5 mL microcentrifuge tube containing 1 mL of ice-cold 100% v/v ethanol and
mixed gently by inverting the tube three times. The ethanol/DNA mixture was incubated
at -80°C for 2 hours before recovery by centrifugation at 12,000 x g for 10 minutes at
4°C. The supernatant was removed and the DNA pellet allowed to air dry for 5 minutes
before re-suspension using 50 l of 1X TE buffer (10 mM TRIS - pH 8, 1 mM EDTA).
The DNA was then quantified using a Nano Drop spectrophotometer (Thermo Fisher).
DNAs were deemed suitable for downstream analysis if the ratio of  = 260 nm to  =
280 nm (A260/A280) measured was between 1.8 – 2.2. The extracts were stored at -80C
until ready for use.
2.6 Standard PCR Reactions
Standard PCR reactions were set up in a total volume of 50 l. To a nuclease-free
0.6 ml tube, the following reagents were added: 500 ng template DNA, 5 l 10X
Advantage2 PCR buffer (Clontech), 0.8 M dNTPs, 0.2 M forward primer, 0.2 M
reverse primer, and 0.5 l Advantage2 DNA polymerase (Takara). The reactions were
gently mixed by pipetting up-and-down followed by a brief centrifugation to collect
reagents at the bottom of the tube. The tubes were then placed into a PTC-200 DNA
Engine Thermal Cycler (Peltier). The reactions were performed using the following
parameters: 95C initial denaturation for 3 minutes followed by 30 cycles of: 95C for 10
seconds, 60C for 30 seconds, and 72C for 1 minutes per kilobase (kb) of expected DNA
product. Samples were then stored at 4C until further use.
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2.7 DNAse Treatment of Total RNA
DNAse treatment was performed with the TURBO DNA-free kit (Invitrogen)
using a modified protocol. Briefly, DNAse treatment was performed on each RNA
extract by adding the following to a sterile, nuclease-free 0.6 ml centrifuge tube: 10 g
total RNA, 5 l 10x TURBO DNAseI Buffer, 1 l TURBO DNase, and nuclease-free
water to a total reaction volume of 50 l. The reaction was mixed gently by flicking and
centrifuged briefly before incubating for 30 minutes at 37°C. The reaction was terminated
by adding 5 l of DNAse Inactivation Reagent followed by incubation at roomtemperature for 2 minutes. The reactions were gently mixed every 30 seconds to keep the
inactivation reagent in solution, per manufacturer’s instruction. The reaction was then
centrifuged at 10,000 x g for 1.5 minutes to pellet the inactivation reagent and
supernatant was then transferred to a clean tube and quantified via a NanoDrop
spectrophotometer (Thermo Fisher).
2.8 First Strand cDNA Synthesis
A total of 500 ng of RNA from the previous step was then reverse-transcribed
with the Maxima First Strand cDNA Synthesis Kit for qRT-PCR, with dsDNase (Thermo
Fisher) using a modified protocol. Briefly, the reaction was set up as follows: 500 ng
RNA, 1 l 10x dsDNase Buffer, 1 l dsDNase, and H2O to a total reaction volume of 10
l. The reaction was then mixed gently and briefly centrifuged before incubating at 37°C
for 2 minutes in a pre-warmed thermal cycler. After briefly chilling the reaction on ice
the following was added to each tube: 4 l 5x Reaction Mix, 2 l Maxima Enzyme Mix,
and 4 l H2O. The reactions were mixed gently and briefly centrifuged before incubating
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at the following parameters: 25°C for 10 minutes, 50°C for 30 minutes, followed by
inactivation at 85°C for 5 minutes. The cDNA was quantified via A260/A280 using a
NanoDrop (Fisher Scientific) spectrophotometer and diluted to a final concentration of
500 ng/l. The diluted cDNA was then stored at 4°C until needed.
2.9 Quantitative Real-Time PCR
Quantitative, real-time PCR (qRT-PCR) was performed on triplicate samples
containing 500 ng of reverse-transcribed RNA using the Maxima SYBR Green/ROX
qPCR Master Mix (2X) (Thermo Fisher). Each reaction contained 0.2 M forward
primer, 0.2 M reverse primer, 12.5 l 2X SYBR Green/ROX Master Mix, 500 ng of
cDNA, and nuclease-free water to a total volume of 25 l. To reduce pipetting errors, a
master mix was assembled for each gene-specific primer set containing all reagents
except cDNA and dispensed in to each tube. 1 l of 500 ng/l cDNA was then
individually added to each tube before starting the reaction. The qRT-PCR reactions were
performed using a CFX96 Touch™ Real-Time PCR Detection System using the
following conditions: 95°C for 10 minutes followed by 40 cycles of 95°C for 15
seconds, 60°C for 30 seconds, 72°C for 30 seconds. Integrity of each run was measured
by melt-curve analysis. Relative expression was determined using the ΔΔCt method after
normalizing to levels of the constitutively expressed house-keeping gene Histone H3
(Hht3) transcript. Primers used in qRT-PCR experiments can be found in Table A1.
2.10 Susceptibility to Superoxides and Peroxides
Yeast phase Histoplasma cultures were grown to mid-log phase. The cultures
were then diluted with pre-warmed, pre-aerated, HMM to an OD600 = 0.1. To generate the
superoxide anions, a 20 mM stock of paraquat dichloride was used to bring 50-ml
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aliquots of the diluted Hc cultures, in triplicate, to a final concentration of 0.5 M, 0.75
M, and 1.0 M, respectively. Immediately before performing the experiment, a 33% v/v
hydrogen peroxide solution (Sigma) was diluted with 1X PBS to make a fresh 50 mM
hydrogen peroxide stock solution. The 50 mM stock was then used to bring 50-ml
aliquots of diluted Hc cultures, in triplicate, to a final concentration of 2.5 mM, 5.0 mM,
and 7.5 mM, hydrogen peroxide, respectively. Controls were also prepared by taking
triplicate 50-ml aliquots of diluted Hc cultures with no additions. The cultures were then
incubated at 37°C in a humidified chamber with shaking at 200 rpm. Every 24-hours, 1ml of each culture was removed and added to a plastic 1.5 ml polystyrene cuvette and
sealed using a polyethylene cuvette cap. The cuvettes were slowly inverted three times to
homogenously mix each sample right before being placed in to the cuvette reader. The
absorbance at 600 nm was measured three times for each sample and recorded.
Measurements were taken every 24 hours for a duration of 5 days (120 hours).
Absorbance measurements at OD600 were taken every 24 hours.
2.11 Susceptibility To Amphotericin B And Ketoconazole
Susceptibility of Hc strains to the antifungal drugs amphotericin b and
ketoconazole was determined by using a microplate-based growth assay (94). Briefly,
Histoplasma yeasts were diluted in a total volume of 10-mls pre-warmed 2X HMM and
50 l aliquots were added to each well of a 96-well, flat-bottomed microplate. Next, 50
l of water only or water supplemented with amphotericin b or ketoconazole,
respectively, at twice the desired concentration (two-fold dilutions from 32 g/ml to 0.03
g/ml final concentrations) was added to each well for a total volume equaling 100 l.
Each well was mixed gently using a multichannel micropipette by pipetting up-and-down
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for 10 seconds carefully, as to not create bubbles. The lid was placed on the microplate
and sealed with Blenderm™ (3M) breathable tape. The plates were then incubated for at
37°C in a humidified chamber with twice daily aeration by incubating plates on a benchtop rocker for 30 minute intervals every 12 hours. The absorbance of each well at 600 nm
was measured using a microplate reader on the fourth day of the experiment. The
measurements were then entered in to GraphPad Prism software where IC50 was
calculated by nonlinear regression.
2.12 Protein Extraction and Quantification
2.12.1 Protein Extraction
Histoplasma capsulatum yeast cultures were grown in liquid HMM at 37°C with
rotary shaking until they reached mid exponential/late exponential growth phase before
harvest (OD600 = 1.2 – 1.8). Five milliliter aliquots of each culture were placed into 15-ml
conical tubes (Corning) and supplemented with 5 l (0.25 mg) of a 50 mg/ml stock of
cycloheximide (Sigma). The tubes were then incubated at room temperature for 10
minutes and centrifuged at 500 x g for 5 minutes. Next, the supernatant was removed and
the cells were washed twice with an equal volume of ice-cold water and re-suspended in
2 ml of ice-cold water. The extracts were then equally divided between two 2-ml screw
cap tubes and allowed to equilibrate to 4°C on ice for 5 minutes before being centrifuged
at 500 x g for 5 minutes. Once the supernatant was removed 200 l of glass beads, 600 l
of protein extraction buffer (60 mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, and 1mM
MgSO4 - pH 7.5), and 6 l of fungal protease inhibitor cocktail (Fisher) was added to
each screw-cap tube. The tubes were allowed to equilibrate to 4°C on ice for 5 minutes.
The total protein was then liberated by bead-beating on a MP Fast Prep – 24 sample
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preparation system (MP Biomedicals) at 4.0 m/s in 20 second intervals with 1 minute
intervals of resting on ice for a total of 4 cycles of vortexing. Each tube was
supplemented with 15 l of 20% w/v SDS and allowed to incubate on ice for 5 minutes.
The lysate was centrifuged at 10,000 x g for 5 minutes at 4°C to pellet any cellular debris.
The supernatant was then recovered and placed into a clean, pre-chilled 1.5 ml
microcentrifuge tube and stored at -80°C until use.
2.12.2 Protein Quantification
Protein concentrations were quantified using the Bradford protein assay (Thermo
Fisher) utilizing bovine serum albumin (BSA; BioRad) as the protein standard. All
reactions were set up in triplicate using a 96-well plate. To begin, Protein Assay
Concentrate (BioRad) was diluted at a ratio of 1:4 (2 ml concentrate + 8 ml water) with
nuclease-free water and mixed well. BSA (BioRad) was provided at a stock concentration
of 2 mg/ml, which was diluted to a final concentration of 0.5 mg/ml and placed on ice.
The diluted Protein Assay reagent was transferred into a sterile, disposable reservoir and
200 l was dispensed into each well of a 96-well plate using a multi-channel
micropipette. For the standard curve, 0.5 µg, 1.0 µg, 2.0 µg, 2.5 µg, 3.5 µg, 4.0 µg, and
5.0 µg of BSA (BioRad) were added to triplicate wells. For unknown protein samples, 1
l of extracted protein was added to triplicate wells. Once all standard and experimental
wells were setup, the plate was placed into the chamber of a microplate reader (Molecular
Devices) and the absorbance of each well read at 595 nm. A standard curve was then
constructed by plotting OD595 nm vs. BSA concentration to extrapolate unknown protein
concentrations. An R2 value > 0.95 was considered suitable for protein quantification.
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2.13 Hydrogen Peroxide Destruction Assay
The hydrogen peroxide destruction assay was performed using a modified
protocol previously described (16, 95). In brief, 33% hydrogen peroxide (Sigma) was
diluted to a final concentration of 10 mM PBS (137 mM NaCl, 10 mM Na2HPO4, 2.7
mM KCl, and 1.8 mM KH2HPO4; pH 7.4), added to a clean 100-ml glass bottle, and
placed on ice immediately before performing the experiment. Eight micrograms of total
protein lysate from each Hc strain was diluted to a final volume of 200 l using PBS and
allowed to equilibrate to 4C on ice. The reaction was assembled right before use by
adding 800 l of the 10 mM hydrogen peroxide solution to the 200 l Hc protein extract,
mixing briefly so not to create bubbles, and placed into a 1 ml quartz cuvette (Sigma).
The quartz cuvette was then immediately placed into the cuvette holder of a microplate
reader (Molecular Devices) where the absorbance at 240 nm and 600 nm was recorded
every 20 seconds for a total of 5 minutes. The above methods were subsequently repeated
for each individual Hc protein extract being examined right before reading the
absorbance to ensure the linear phase of catalase activity occurred in the measured time
frame of the assay.
2.14 Macrophage Infections
RAW 264.7 macrophages (ATCC TIB-71), Mus musculus, were thawed from a
frozen stock, centrifuged at 500 x g for 5 minutes in a swing-bucket centrifuge, and resuspended in an equal volume of fresh, pre-warmed 1X DMEM supplemented with 10%
v/v FBS, 50 µg/ml ampicillin, and 100 µg/ml streptomycin. The aliquot was then added
to a T-75 cell culture flask containing 20-ml of 1X DMEM, with supplements mentioned
above, and incubated at 37°C in a humidified incubator with 5% CO2 and 95% room air
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atmosphere for 24 hours. Once the culture reached ~80% confluence, the macrophages
were dissociated with 0.25% trypsin-EDTA (Gibco), enumerated by microscopy with a
hemacytometer, and 5 x 104 macrophages were seeded into each well of a 24-well tissue
culture plate in a total volume of 1-ml. For assays that required macrophage activation,
the macrophages were allowed to adhere to the culture plate for 20 minutes before 100
units (U) of murine recombinant interferon-gamma (IFN) (Invitrogen) was added to
each well to stimulate the macrophages. The seeded 24-well tissue culture plates were
then incubated at 37°C in a humidified incubator with 5% CO2 and 95% room air
atmosphere for 24 hours to allow the cells to grow to confluence. Once the macrophages
reached ~80% confluence, the wells were washed with 1X DPBS three times. For coinfection, Histoplasma yeasts were enumerated via a hemacytometer and diluted to 2 x
105 cells/well, 2 x 106 cells/well, or 1 x 107 cells/well, which corresponds to a multiplicity
of infection (MOI) (macrophage-to-yeast) ratio of 1:1, 1:10, or 1:50, respectively, in
HMM-M (HMM supplemented with 10% FBS, 584 mg/L L-glutamine, and 3.7 g/L
sodium bicarbonate). The macrophage-yeast co-cultures were then incubated at 37°C in a
humidified incubator with 5% CO2 and 95% room air atmosphere for 2 hours to facilitate
phagocytosis. Each well was then subsequently washed with 1X DPBS three times to
remove any un-phagocytized Hc yeasts. The wells were then re-suspended in an equal
volume of fresh, pre-warmed HMM-M and incubated at 37°C in a humidified incubator
with 5% CO2 and 95% room air atmosphere. At 24-hours post-infection, the culture
medium was removed from each well, washed with DPBS three times, and an equal
volume of water added to facilitate macrophage lysing. The macrophages were
mechanically lysed by scraping the bottom of each well with a sterile micropipette tip.
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Dilutions of each lysate were plated on to triplicate HMM plates and incubated at 37°C
until visible colonies appeared. Yeast survival was determined by viable colony forming
units (CFUs) as a percentage survival of un-activated, recovered colonies.
2.15 Phagocytosis Assay
Phagocytosis assays were performed using a modified protocol from Cordero et
al. (96). RAW 264.7 macrophages were plated onto 6-well tissue culture plates
containing an 18 mm diameter glass coverslip coated in poly-L-lysine at 1.5 x 105 cells
per well in a total volume of 3-ml of 1X DMEM. The macrophages were incubated for
24-hours at 37°C in a humidified incubator with 5% CO2 and 95% room air atmosphere
to allowed adherence to the coated glass coverslip. Histoplasma yeast cultures were
grown in HMM at 37°C to mid-log growth phase before 10-ml aliquots were removed
and labelled with 40 g/ml of NHS Rhodamine (Thermo-Fisher) for 30 minutes at 25°C.
The cells were then washed with an equal volume of 1X DPBS three times before resuspending in an equal volume of pre-warmed HMM and enumerated by a
hemacytometer. For co-infection, the media was removed from each well of
macrophages, washed with 1X DPBS three times, and 7.5 x 105 Hc cells (MOI = 1:5)
were added to each well in a total volume of 3-ml of pre-warmed HMM-M. The plates
were incubated for two hours at 37°C in a humidified incubator with 5% CO2 and 95%
room air atmosphere to facilitate phagocytosis of the labelled Hc yeasts. After the
incubation, the plates were washed with 1X DPBS three times, fixed for 15 minutes at
25°C with 3-mls of 4% formaldehyde solution in PBS, and washed with 1X DPBS three
times. Each coverslip was then removed from their well, placed onto a clean glass
microscope slide containing 4 l of hard set mounting medium (Vecta-Shield), and
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allowed to set for 10 minutes before sealing with nail polish. The slides were allowed to
dry in the dark overnight at 25°C before being stored long term in a slide box at 4°C until
microscopic analysis. Images were obtained using a Zeiss 510 Meta confocal microscope
using DIC and the 650 nm laser using immersion oil at 60X magnification. At least 8
different images were obtained, each of a different field of view. The number of
macrophages and the number of Hc yeasts within each were recorded for each field of
view. At least 200 macrophages were counted for each Hc strain being analyzed. The
percentage of phagocytosis was determined by calculating the ratio of macrophages
containing Hc yeasts divided by the total number of macrophages enumerated. The
phagocytic index was determined by calculating the average number of Hc yeasts inside
of the recorded macrophages.
2.16 Northern Blot Procedures
2.16.1 Denaturing Gel Electrophoresis
Before proceeding with the Northern blotting protocol, all plastic and glassware
was treated with a 2% v/v solution of Absolve (Perkin Elmer) to remove any
contaminating RNAse and briefly rinsed with nuclease free, sterile water. Next, a 1.2 %
w/v agarose gel was prepared by adding 0.6 g agarose to 45 ml of nuclease free water,
microwaving until molten, and allowed to cool down to ~65C. Once cooled, 10X MOPS
buffer was added to a final concentration of 1X and the molten solution was poured into a
mini gel box (CBS Scientific). RNA samples were prepared for Northern blotting by
adding 10 µg of total RNA, in a total volume of 4.5 µl, to the following: 10 µl 99.8%
deionized formamide (40% v/v), 3.5 µl 37% formaldehyde (5.18% v/v), 2 µl 10X MOPS
buffer (0.8X), and 1 µl of 1 mg/ml ethidium bromide (1µg) . The tubes were then mixed
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briefly by pipetting up-and-down, incubated at 55C for 15 minutes, and placed on ice
until ready to load the gel. A total of 4 µl of 6X gel loading dye (Ameresco) (5% v/v) was
added to each prepared RNA tube immediately before loading the gel. The gel was then
loaded and electrophoresis was conducted in 1X MOPS buffer at 75 V for 1.5 hours. The
gel was then subsequently transferred onto a positively charged nylon membrane
(Millipore) overnight using a downward blotting apparatus (Turbo Blotter) with 20X SSC
(3 M NaCl, 0.3 M Na2C6H6O7, pH 7.0). After transfer, the membrane was placed on a
clean piece of Whatman #1 filter paper and dried at 80C for 20 minutes. The membranes
were then cross-linked by placing in a biosafety cabinet with the UV light ( = 254 nm)
on for 10 minutes (120 mJ/cm2). The membrane was then stored in a clean, dark place
until ready to hybridize.
2.16.2 Generating 32P-dATP Radiolabeled Probes
DNA templates for probe synthesis were amplified by PCR using gene-specific
primers for each respective target from wild-type genomic DNA templates according to
standard PCR conditions presented above. Radiolabeled probes were generated with the
DECAprime II DNA labeling kit (Invitrogen) using a modified protocol. First, a random
decamer solution was added to 100 ng of each DNA template and incubated at 95 C for
5 minutes. Each tube was then snap-frozen using a -80C isopropanol bath (80%
isopropanol / 20% water) and placed on ice. The following reaction was subsequently set
up in a new 0.6 ml microfuge tube for each respective probe to be generated: 5 µl 5X
reaction buffer (-dATP), 5 µl 32P-dATP, and 1 µl Exo-Klenow fragment (Ambion).
Each decamer/DNA solution was added to their respective tube containing 32P-dATP
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solution, gently mixed by pipetting up-and-down, and incubated at 37C for 30 minutes
in a thermal cycler to generate radiolabeled probes. Once the incubation was complete,
the following was added to each tube: 75.5 µl nuclease-free water, 1 µl 5 mg/ml linear
acrylamide (5 µg), 11 µl 3M C2H3NaO2 (0.1M), and 220 µl 100% v/v ethanol (66.2 %
v/v). The tubes were mixed gently by inverting each tube 2-3 times and then centrifuged
at 12,000 x g for 15 minutes. The supernatant was then removed using a pipette and the
pellet was dissolved in 100 µl of nuclease-free water. At this point, each tube was held in
front of a Geiger counter to test for efficient labeling. Immediately before the probes
were to be added to the hybridizing blots, they were incubated at 95C for minutes,
immediately snap-frozen in a isopropanol bath, and placed on ice.
2.16.3 Hybridization and Imaging
Hybridization solution (0.5 M phosphate buffer, pH 7.0, 5% w/v SDS) was prewarmed to 65C before being placed into a glass hybridization tube containing the
prepared membrane and allowed to pre-hybridize at 65C for 30 minutes. Next, 100 µl of
the prepared radiolabeled probe was added and the membrane was probed overnight at
65C. The next morning, the hybridization solution was removed and placed in to a 50ml conical tube for storage until re-use. The membrane was then subjected to a series of
washes to remove any un-bound probe as follows: once with wash solution 1 (1X SSC,
0.5% v/v SDS) and twice with wash solution 2 (0.1X SSC, 0.1% v/v SDS) for 15 minutes
each. The membrane was then wrapped with plastic wrap and placed into a phosphor
screen cassette (Molecular Dynamics) and a storage phosphor screen (Kodak) was placed
on top. The cassette was then gently closed and allowed to develop, undisturbed, for 24
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hours. The phosphor storage screen was then imaged using a Typhoon FLA 7000
imaging system.
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CHAPTER III – RESULTS
3.1 Histoplasma capsulatum DDR48
The DDR48 gene was originally isolated in H. capsulatum in our lab from a
subtractive cDNA hybridization library that was enriched to identify transcripts whose
mRNA expression was up-regulated in Histoplasma mold compared to Histoplasma
yeasts under optimal liquid growth conditions (HMM) (97). Transcripts identified in this
library were named as “mold-specific” plus the number corresponding to when it was
identified chronologically (e.g. mold-specific 8; MS8). Using this naming system,
DDR48 was originally referred to as mold-specific 95 (MS95). We performed a
reciprocal protein BLAST of MS95 using the Saccharomyces Genome Database (SGD)
and found it to be an orthologue of the S. cerevisiae DDR48 gene, sharing 48.6% identity
and a corresponding E-value of 7.0 x 10-22 (Table 3.1). For continuity between fungal
species in the literature, we updated the name from MS95 to DDR48. The H. capsulatum
DDR48 locus (HcDDR48) contains a 1500 base-pair (bp) transcript containing 3 introns,
whose mature mRNA product translates in to a 32.9 kD protein (Accession Number:
GG663365) that is 314 amino acids in length (Figure 3.1). Since the function of DDR48
is unknown, we performed a protein BLAST to search for conserved features. We found
that Histoplasma DDR48 contains a total of 9 conserved SNN(N/D)DSYG repeats, which
is consistent with the DDR48 protein found in other fungi (Figure 3.1). Using the NCBI
Conserved Protein Domain Family tool, we found Histoplasma DDR48 to contain a
conserved PTZ00110 (CDD) helicase domain belonging to the CL36512 domain
superfamily. The PTZ00110 domain family consists of DEAD-box ATP-dependent RNA
helicases involved in various aspects of RNA biosynthesis, maturation, and degradation
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Table 3.1
Max
Score

Total
Score

Query
Coverage

E-value

Percent
Identity

Blastomyces dermatitidis

282

282

93%

1.00E-88

60.31%

Candida albicans

109

181

79%

2.00E-24

52.76%

Candida glabrata

98

482

80%

4.00E-19

46.07%

Coccidioides immitis

101

101

98%

2.00E-20

35.73%

Emmonsia crescens

259

372

99%

3.00E-80

64.63%

Microsporum canis

125

125

96%

9.00E-30

42.74%

Paracoccidioides brasiliensis

127

127

92%

9.00E-31

48.51%

Penicillium brasilianum

115

188

91%

2.00E-26

49.33%

Saccharomyces cerevisiae

106

584

81%

7.00E-22

48.60%

Species

Table 3.1 DDR48 Fungal BLAST
Fungal BLAST table of the H. capsulatum DDR48 amino acid sequence from the
Saccharomyces Genome Database (SGD) Fungal BLAST Suite.
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Figure 3.1
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Figure 3.1 DDR48 mRNA & Amino Acid Sequence
HcDDR48 mature mRNA transcript and amino acid sequence. The start codon and stop
codon are in bold as well as the single letter abbreviation for the encoded amino acid.
Repeats of SNN(N/D)DSYG are highlighted.
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Figure 3.2
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Figure 3.2 DDR48 Phylogenetic Tree
Phylogenetic analysis showing the relationship between Histoplasma DDR48 and DDR48
in other fungi. Accession numbers are given for proteins from Ustilago maydis (Uma),
Talaromyces marneffei (Tma), Fusarium graminearum (Fgr), Fusarium fujikuroi (Fju),
Cryptococcus neoformans var grubii (Cne), Trichophyton rubrum (Tru), Coccidioides
immitis (Cim), Paracoccidioides brasiliensis (Pbr), Histoplasma capsulatum (Hca),
Blastomyces dermatitidis (Bde), Aspergillus flavus (Afl), Aspergillus oryzae (Aor),
Penicillium brasilianum (Pba), Saccharomyces cerevisiae (Sce), Candida albicans (Cal)
and Schizosaccharomyces pombe (Spo).
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(98, 99). To ascertain phylogeny of Histoplasma DDR48, we constructed a phylogenetic
tree. We determined that Histoplasma DDR48 is most closely related to Paracoccidioides
brasiliensis and Blastomyces dermatitidis, which is to be expected since the fungi are
closely related dimorphic, pathogenic fungi (Figure 3.2).
To confirm the results of the cDNA library that DDR48 transcript levels are
enriched in Histoplasma mold under optimal growth conditions, we performed
quantitative, real-time PCR (qRT-PCR) and northern blot analysis on Histoplasma mold
and Histoplasma yeasts from two laboratory strain, G186AR and G217B, to quantify
DDR48 mRNA levels. qRT-PCR revealed that DDR48 is expressed 6-fold higher in
Histoplasma mold versus Histoplasma yeasts, compared to the constitutively expressed
Histone H3 gene (HHT1) in both strains of H. capsulatum (Figure 3.3). The northern blot
confirmed that DDR48 is expressed at a much higher level in the mold morphotype as
compared to the yeast morphotype, relative to the Histone H3 gene loading control
(Figure 3.3). These results suggest that DDR48 is a mold specific gene in H. capsulatum.
3.2 DDR48 Knockout and Complement Confirmation
To enable functional characterization of DDR48, a mutant strain was created in
our lab that lacks a functional copy of the DDR48 gene. We replaced the DDR48 openreading frame (ORF) with the Escherichia coli hygromycin B phosphotransferase gene
(HPH) via the allelic replacement method. Insertion of the HPH gene allows for selection
of transformants by providing positive transformants with natural resistance to the
aminoglycoside compound hygromycin B. The HPH resistance cassette was flanked with
530 bp of DNA sequence upstream of the DDR48 ORF and 680 bp of DNA sequence
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downstream of the DDR48 ORF, providing homologous sequence to guide and enable a
successful homologous recombination event (Figure 3.4A).
To confirm successful genomic replacement of the DDR48 ORF with the HPH
resistance cassette, we performed an endpoint PCR using primers that target DDR48,
HPH, and HHT1. A 200 bp product corresponding to the native DDR48 locus was only
detected in the DDR48 (+) strain; whereas, a 320 bp product corresponding to the
inserted HPH gene was only detected in the ddr48 strain (Figure 3.4B). Amplification
of a 180 bp product corresponding to HHT1 was present in both strains, indicating that
the genomic DNA used was suitable for PCR analysis (Figure 3.4B).
We also created a complement strain in which we rescued native DDR48
expression to ensure that any functional deficits observed in the ddr48 strain were
indeed due to the lack of a copy of DDR48 and not due to any pleiotropic effects. A
telomeric expression vector containing a copy of the DDR48 ORF, its native promoter,
and the URA5 gene was inserted into ddr48 yeasts to rescue endogenous DDR48
expression. The telomeric repeats enable stable episomal maintenance of the vector
containing the rescue copy of DDR48 in H. capsulatum. The parental strain (WU27)
lacks a functional copy of the URA5 gene, which produces uracil auxotrophy; therefore,
providing a copy of the URA5 gene on a plasmid enables positive selection of
transformants with uracil. We also wanted to confirm successful deletion and rescue of
DDR48 expression at the mRNA level by performing qRT-PCR analysis and a northern
blot on mRNAs extracted from the DDR48 (+), ddr48, and the ddr48 + DDR8 strains,
respectively. As seen in Figure 3.4C,
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Figure 3.3

Figure 3.3 qRT-PCR & Northern blot of DDR48
qRT-PCR and northern blot were performed on mold-phase and yeast-phase Hc samples
from two clinically relevant strains, G186AR and G217B. All data generated were
performed on three technical replicates and at least two biological replicates. Data is
graph as mean  standard error of the mean (SEM).
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Figure 3.4

Figure 3.4 Confirmation of DDR48 Knockout
A) Allelic replacement schematic for deleting DDR48. B) Endpoint PCR of DDR48 (+)
yeast gDNA and ddr48∆ yeast gDNA using primers for Histone H3 (HHT1),
Hygromycin phosphotransferase (HPH), and DDR48 to confirm successful allelic
replacement of the HcDDR48 ORF. C) qRT-PCR and northern blot results confirming
deletion of HcDDR48 at the mRNA level. All data generated were performed on three
technical replicates and at least two biological replicates. Data is graph as mean 
standard error of the mean (SEM).
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there was no DDR48 expression detected in the ddr48 strain and DDR48 transcript
levels were rescued to near wild-type levels in the ddr48 + DDR8 strain. The
constitutive loading control HHT1 was present in all three strains, indicating that the
mRNA was not degraded and thus competent for downstream applications (Figure 3.4B).
These results confirm that we have indeed generated a mutant Histoplasma strain devoid
of DDR48 expression and a functionally complemented strain that rescued native DDR48
expression.
3.3 DDR48 Is Not Essential For Dimorphism
Most phase-specific genes that have been characterized in H. capsulatum are
involved in maintenance of the growth program in which their expression is enriched
(97). Since DDR48 expression is enriched in Histoplasma mold, we sought to determine
if DDR48 is involved in maintenance of the mycelial-phase of growth. We determined
that DDR48 is not essential for maintaining the mold morphotype because deleting
DDR48 did not affect the maintenance of the Histoplasma mold or Histoplasma yeast
morphotypes (Figure 3.5). To determine if there were any growth deficits present in the
ddr48 mutant, we performed a growth curve comparing wildtype, ddr48 mutant, and
complemented Histoplasma yeasts in rich growth media, HMM, and a minimal nutrient
growth media, 3M Minimal Media. There were no observable differences in growth
between the wildtype and the ddr48 mutant strains in either HMM (Figure 3.6A) or 3M
media (Figure 3.6B) at any timepoints recorded. To determine if there was a statistical
difference between the strains at each timepoint, a two-way ANOA was performed using
Tukey’s multiple comparisons test, which showed no significant differences between
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DDR48-expressing and ddr48 mutant cells in HMM or 3M mediums. It is worth
mentioning that all three strains grew significantly slower in 3M medium, although this is
to be expected since HMM is a nutrient dense media; whereas, 3M media provides only
the essentials to promote Histoplasma growth. These results only show growth in
mediums that contain all the essentials to support Growth. To determine if DDR48 is
involved in nutrient acquisition or metabolism we would need to perform this experiment
in drop out mediums where we can modify or restrict one component at a time.
3.4 DDR48 Is Required For Optimal Survival Of Histoplasma Yeasts When Exposed
To Oxidative Stress
Since investigators have shown DDR48 is involved in response to oxidative stress
in S. cerevisiae and C. albicans, we wanted to determine if DDR48 is involved in
oxidative stress in H. capsulatum. We first sought to determine if the DDR48 gene was
responsive to the presence of oxidative stress at the transcriptional levels. To do this, we
analyzed mRNA levels of Histoplasma yeasts and mold before and after the addition of
the superoxide generator, paraquat. In Histoplasma yeasts, we found that DDR48 mRNA
levels increased by 4.2-fold 15 minutes after the addition of paraquat, reaching a
maximum upregulation of 5.5-fold within 30 minutes post-addition. Within 60 minutes
after adding paraquat, DDR48 mRNA levels began returning to basal levels as seen by
mRNA levels only 3.3-fold higher than the no treatment control. At 120 minutes after
paraquat addition, DDR48 mRNA levels return to those observed in the no treatment
control (Figure 3.7). There were no detectable changes in DDR48 mRNA levels in
Histoplasma mold at any of the timepoints measured (Figure 3.7). Combining our data
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Figure 3.5 Growth on Solid Medium
Growth of wild-type (DDR48 (+)), ddr48 knock-out mutant (ddr48), and the DDR48
complemented (ddr48 + DDR48) Histoplasma capsulatum strains on solid HMM media
to confirm no visible growth differences between the strains.
Figure 3.6

Figure 3.6 Liquid Growth Curve
Growth of wild-type (DDR48 (+)), ddr48 knock-out mutant (ddr48), and the DDR48
complemented (ddr48 + DDR48) Histoplasma capsulatum yeasts in rich HMM broth
(A) or 3M minimal medium broth (B).
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demonstrating that DDR48 mRNA levels were already 6-fold higher in Histoplasma
mold with the present data where we observed no changes in mRNA levels after the
addition of paraquat, we can conclude that DDR48 is constitutively expressed in the mold
phase of H. capsulatum. In contrast, we have shown that DDR48 expression is inducible
in Histoplasma yeasts by exposure to oxidative stress, where DDR48 mRNA levels rise
to those observed basally in Histoplasma mold. To determine if constitutive expression of
DDR48 in Histoplasma mold is observed when cells are exposed to other cellular
stressors, we performed the same mRNA experiments discussed above with the addition
of the DNA/RNA biosynthesis inhibitor 5-fluorocytosine (5FC) or the DNA damaging
agent 4-nitroquinoline-1-oxide (4NQO), which can be found in Appendix C. We found
that 5FC and 4NQO also induce DDR48 expression in Histoplasma yeasts. We also
conclude that DDR48 expression is constitutive in Histoplasma mold, even when
challenged with oxidative stress, DNA damage, or UV stress. This phenomenon could be
because H. capsulatum is more readily exposed to environmental stressors in the
environmental mold form; therefore, keeping stress response elements constitutively on
can confer a survival advantage.
Since we have demonstrated that DDR48 is involved in oxidative stress response,
we determined if there are any differences in growth between wild-type and ddr48
strains when subjected to oxidative stress. For Histoplasma yeasts, we performed a series
of growth curves where rich HMM medium was supplemented with various
concentrations of paraquat or hydrogen peroxide and monitored growth over time. We
chose to included hydrogen peroxide since superoxides that are generated by paraquat are
readily broken down in to peroxides, thus Histoplasma cells will be challenged with both
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reactive oxygen species (ROS) in vivo (100). DDR48 (+) yeast growth was 98%, 91%,
and 78%, after 3 days of growth in the presence of 0.5 M, 0.75 M, and 1.0 M
paraquat, respectively (Figure 3.8A, Figure 3.9). Growth of ddr48 yeasts was
significantly decreased with growth values of only 69%, 54%, and 40%, respectively.
Growth was rescued in the complemented ddr48 + DDR48 strain with values of 97%,
95%, and 95%, respectively (Figure). Growth of DDR48 (+) yeasts after exposure to
hydrogen peroxide was 98%, 99%, and 99%, in peroxide concentrations of 2.5 mM, 5.0
mM, and 7.5 mM, respectively (Figure 3.8B, Figure 3.10). In contrast, ddr48 yeast
growth was only 82%, 38%, and 11%, respectively. Growth of ddr48 + DDR48 yeasts
were restored to levels seen in DDR48 (+) cells with 98%, 96%, and 99% survival,
respectively. These results demonstrate that DDR48 is required for combatting oxidative
stress conditions in the form of superoxides and peroxides in Histoplasma yeasts, which
explains the upregulation of DDR48 mRNAs in response to oxidative stress.
The next question we sought to answer is how the loss of DDR48 is leading to
increased sensitivity to ROS. To determine the enzymatic activity of Histoplasma
catalases, we performed a peroxide degradation assay and determined the total catalase
activity of each Histoplasma strain. The assay exploits the fact that hydrogen peroxide
absorbs light at 240 nm, thus a decrease in peroxide concentration is accompanied by a
subsequent decrease in absorbance at 240 nm. By adding a known amount of hydrogen
peroxide and the same Histoplasma protein concentration from each strain, we were able
to determine the degradation rate (change in absorbance at 240 nm) of hydrogen
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Figure 3.7

Figure 3.7 DDR48 Gene Expression Post-Paraquat
qRT-PCRs were performed on mold and yeast-phase wild-type (DDR48 (+)) cells under
optimal conditions (control) and 0.25 hour, 0.5 hour, 1 hour, and 2 hours after the
addition of 100 μM Paraquat. Histone H3 was used as a normalizer gene utilizing the
ΔΔct method to normalize mRNA levels to the no paraquat control (dashed line). All data
generated were performed on three technical replicates and at least two biological
replicates. Data is graphed as mean  standard error of the mean (SEM). Statistical
analysis were performed using a 2-way ANOVA followed by Tukey’s multiple
comparisons test.
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Figure 3.8

Figure 3.8 Relative Growth Under Oxidative Stress
Survival of DDR48 (+) yeasts, ddr48 yeasts, and ddr48 + DDR48 yeasts after 4-days
of growth in liquid HMM broth supplemented with various concentrations of paraquat
(A) or hydrogen peroxide (B). Data is graphed as mean survival  standard error of the
mean (SEM). Percent survival was normalized to DDR48 (+) no treatment control growth
levels. Statistical analysis were performed using a 2-way ANOVA followed by Tukey’s
multiple comparisons test.
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Figure 3.9

Figure 3.9 Paraquat Growth Curve
Growth of DDR48 (+),ddr48, and ddr48 + DDR48 Hc yeasts in rich HMM broth only
(A) or supplemented with 0.5 M paraquat (B), 0.75 M paraquat (C), or 1 M paraquat
(D).
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Figure 3.10

Figure 3.10 Peroxide Growth Curve
Growth of DDR48 (+),ddr48, and ddr48 + DDR48 Hc yeasts in rich HMM broth only
(A) or supplemented with 2.5 mM H2O2 (B), 5 mM H2O2 (C), or 7.5 mM H2O2 (D).
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peroxide, which correlates to the amount of endogenous catalase activity in the protein
extract provided. We began by performing a series of standard curves to optimize the
assay reaction conditions. The peroxide degradation assay was performed with various
concentrations of Histoplasma protein extracts. We determined that concentrations
ranging from 2 g/ml – 16 g/ml yield linear measurements (R2 = 0.9833) (Figure
3.11A). We also determined the optimal time in which the assay progresses in a linear
fashion to be between 10 – 30 seconds after reaction initiation (R2 = 0.9874) (Figure
3.11B). Once optimal reaction conditions were determined, we performed the destruction
assay using protein extracts from DDR48 (+) yeasts, ddr48 yeasts, and ddr48 +
DDR48 yeasts (Figure 3.12). We determined that the rate of hydrogen peroxide
destruction was severely decreased in ddr48 yeasts. Hydrogen peroxide destruction was
calculated to be 0.95 mmol/min in DDR48 (+) yeasts. Peroxide destruction was
significantly decreased (p < 0.0001; ANOVA) by 57% in ddr48 yeasts with a rate of
destruction of 0.41 mmol/min (Figure 3.13A). As expected, degradation rate was brought
back to near wild-type levels in ddr48 + DDR48 yeasts, as the degradation rate was
determined to be 1.07 mmol/min. Furthermore, enzymatic activity of total catalases was
determined for each strain to confirm that the decrease in degradation rate was due to a
decrease in catalase activity. The total catalase activity was determined to be 138
U/min/ml for DDR48 (+) yeasts and 149 U/min/ml for ddr48 + DDR48 yeasts; whereas
total catalase activity of ddr48 yeasts was determined to be 49 U/min/ml, which was a
decrease of 64% compared to DDR48 (+) yeasts (Figure 13.3B).
We also performed a superoxide dismutase (SOD) assay to determine if the loss of
DDR48 leads to changes in SOD enzymatic activity. We calculated cytosolic SOD
51

activity and total SOD activity for DDR48 (+) yeasts, ddr48 yeasts, and ddr48 +
DDR48 yeasts. In DDR48 (+) yeasts, cytosolic SOD activity was found to be 3.16 U/mg
protein while total SOD activity was 4.21 U/mg protein (Figure 3.14). Cytosolic SOD
activity of ddr48 yeasts was determined to be 0.64 U/mg protein, which is a significant
decrease (p < 0.0001; ANOVA) by 80%. Total SOD activity of ddr48 yeasts was also
significantly decreased (p < 0.0001: ANOVA) by 64% with activity equal to 1.49 U/mg
protein. Cytosolic and total SOD activity was restored to near wildtype levels in ddr48
+ DDR48 yeasts with cytosolic SOD activity equal to 3.36 U/mg protein and total SOD
activity equal to 3.79 U/mg protein (Figure 3.14). These results confirm that the loss of
DDR48 decreases the amount of catalase and superoxide dismutase enzymatic activity in
optimal conditions. To determine if the loss of catalase and SOD enzymatic activity in
ddr48 yeasts is due to a lesion at the transcriptional level versus translational level, we
performed gene expression analysis on Histoplasma catalase and superoxide dismutase
genes in HMM alone or HMM supplemented with paraquat. The cytosolic superoxide
dismutase SOD1 was down-regulated by 93% (13.6-fold down-regulated) in ddr48 cells
when compared to DDR48 (+) cells under optimal (HMM) conditions. SOD1 mRNA
expression is restored to levels seen in DDR48 (+) yeasts (1.4-fold) in the ddr48 +
DDR48 strain, successfully complementing the DDR48 deletion. SOD1 transcription
levels were measure 30 minutes after paraquat addition and found to be increased by
14.5-fold in DDR48 (+) yeasts and 14.7-fold in ddr48 + DDR48 yeasts. SOD1
transcription levels in the ddr48 strain only increased to basal levels observed in the
DDR48 (+) no
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Figure 3.11

Figure 3.11 Degradation Standard Curves
Standard curves of absorbance vs. Hc protein concentration (A) and absorbance vs. assay
time (B) to optimize peroxide degradation assay.

Figure 3.12

Figure 3.12 Peroxide Degradation Rate
Peroxide degradation rate, measured by change in absorbance at 240 nm, for DDR48
(+),ddr48, and ddr48 + DDR48 Hc strains.
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Figure 3.13

Figure 3.13 Peroxide Degradation & Catalase Activity
Hydrogen peroxide degradation rate (A) and relative catalase protein activity (B) of
DDR48 (+), ddr48, and ddr48 + DDR48 Hc strains. Data is graphed as mean 
standard error of the mean (SEM). Statistical analysis were performed using a 1-way
ANOVA.
Figure 3.14

Figure 3.14 SOD Assay
Superoxide dismutase (SOD) enzymatic activity of DDR48 (+), ddr48, and ddr48 +
DDR48 Hc strains. Data is graphed as mean  standard error of the mean (SEM).
Statistical analysis were performed using a 1-way ANOVA.
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treatment control samples (1.2-fold); however, since SOD1 mRNA levels in ddr48
yeasts were only 0.07-fold before the addition of paraquat, SOD1 was still increased by
roughly 14-fold 30 minutes after exposure to paraquat (Figure 3.15B). These results
demonstrate that DDR48 modulates the basal transcription rate of SOD1 and not
impairing cellular signaling in response to oxidative stress.
Gene expression results show a 3.1-fold decrease in basal expression of the
cytosolic catalase, CatP, in ddr48 yeasts grown in optimal (HMM) growth conditions,
compared to DDR48 (+) basal mRNA levels. CatP expression is restored to 1.1-fold in
the ddr48 + DDR48 strain, successfully complementing the DDR48 deletion. CatP
expression is increased by 7.1-fold in DDR48 (+) yeasts 30 minutes after exposure to
paraquat. CatP mRNA levels do not change in ddr48 yeasts after paraquat exposure.
Expression of CatP increased by 7.8-fold in the complemented ddr48 + DDR48 strain
after paraquat exposure, thus rescuing CatP expression to levels seen in DDR48 (+)
(Figure 3.15D). These results suggest that the loss of DDR48 leads to a lesion between
cell signaling in response to oxidative stress and the cytosolic catalase CatP. There were
no changes in transcriptional changes of CatB, an extracellular catalase (Figure 3.15C).
Our results show a 8.3-fold decrease in basal expression of the cytosolic catalase, CatA,
in ddr48 yeasts grown in optimal (HMM) growth conditions, compared to the DDR48
(+) strain, that is restored to 1.3-fold in the ddr48 + DDR48 yeasts. CatA expression is
increased by 4.1-fold in DDR48 (+) yeasts 30 minutes after exposure to paraquat. mRNA
levels in ddr48 yeasts increased by 5.9-fold after paraquat exposure. Expression of
HcCatA increased by 3.6-fold in the complemented, ddr48 + DDR48, strain after
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paraquat exposure, consistent with complementation (Figure 3.15A). It is important to
note that while CatA mRNA levels did not increase as much in magnitude as compared to
DDR48 (+) yeasts they did increase by the same fold-change, since basal mRNA levels
were already down before paraquat addition. This indicates that the loss of HcDDR48
leads to a lesion in basal regulation of CatA expression, not in response to stress. These
results show that DDR48 plays a dynamic role in Histoplasma’s response to oxidative
stress for some genes and basal transcription rates of others.
Since ddr48 yeasts are able to proliferate, albeit, at much lower rates, under
oxidative stress, we examined other components of the oxidative stress response. We
performed qRT-PCRs on the cytosolic thioredoxin reductase Trr1 (Figure 3.15C), the
cytosolic thioredoxin Trx1 (Figure 3.16D), the glutamate-cysteine ligase Gsh1 (Figure
3.16A), and the glutathione synthetase Gsh2 (Figure 3.16B) in optimal growth conditions
(HMM) and oxidative stress (HMM + paraquat) in all three strains. In DDR48 (+) yeasts,
after 30 minutes of exposure to paraquat, there were no significant changes in mRNA
levels of HcTrr1, HcTrx1, HcGsh1, or HcGsh2. In ddr48 yeasts exposed to paraquat,
HcTrr1 was upregulated by 4.3-fold, HcTrx1 by 5.9-fold, HcGsh1 by 5.7-fold, and
HcGsh2 by 9.6-fold. Transcript levels in ddr48 + DDR48 yeasts matched those seen in
DDR48 (+) yeasts. These results suggest that the glutathione-dependent oxidative stress
system is compensating for the loss of catalase and superoxide dismutase activity see in
ddr48 yeasts.
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Figure 3.15

Figure 3.15 Oxidative Stress Gene Expression
Gene expression of Hc oxidative stress genes. qRT-PCRs were performed on DDR48 (+),
ddr48, and ddr48 + DDR48 yeasts under optimal conditions (control) and 30 minutes
after the addition of 0.5 M Paraquat. Histone H3 was used as a normalizer gene utilizing
the ΔΔct method to normalize mRNA levels to the no paraquat control (dashed line). All
data generated were performed on three technical replicates and at least two biological
replicates. Data is graphed as mean  standard error of the mean (SEM). Statistical
analysis were performed using a 2-way ANOVA followed by Tukey’s multiple
comparisons test.
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Figure 3.16

Figure 3.16 Re-Dox Gene Expression
Gene expression analysis of Hc redox genes. qRT-PCRs were performed on DDR48 (+),
ddr48, and ddr48 + DDR48 yeasts under optimal conditions (control) and 30 minutes
after the addition of 0.5 M Paraquat. Histone H3 was used as a normalizer gene utilizing
the ΔΔct method to normalize mRNA levels to the no paraquat control (dashed line). All
data generated were performed on three technical replicates and at least two biological
replicates. Data is graphed as mean  standard error of the mean (SEM). Statistical
analysis were performed using a 2-way ANOVA followed by Tukey’s multiple
comparisons test.
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3.5 The Loss Of DDR48 Leads To Decreased Survival Of Histoplasma Yeasts In
Resting And Activated Macrophages
Since macrophages respond to Histoplasma capsulatum (Hc) infection by
generating reactive oxygen species (ROS), we asked if the lack of DDR48 altered
intracellular survival of Histoplasma yeasts within resting and activated macrophages..
We first asked if HcDDR48 mRNA levels were responsive to phagocytosis by
macrophages. We performed HcDDR48 gene expression analysis (qRT-PCR) on DDR48
(+) yeasts in HMM (no treatment control), 4 hours post-infection with macrophages, and
24 hours post-infection with macrophages to determine if DDR48 was induced when
within macrophages.. We found that DDR48 mRNA levels increase by 9.9-fold 4 hours
after being phagocytosed by macrophages and 14-fold within 24 hours post-infection
(Figure 3.17). Furthermore, at an MOI of 1:1 (macrophage-to-yeast), 82% of DDR48 (+)
yeasts were recovered after infection with resting macrophages, and 59% of DDR48 (+)
yeasts were recovered after infection with activated macrophages, after 24 hours of
incubation. In contrast, 42% and 26% of ddr48 yeasts were recovered after infection
with resting and activated macrophages, respectively. Hc survival within macrophages
was rescued to near wild-type (DDR48 (+)) levels in the complemented ddr48 +
DDR48 strain with 76% and 48% recovery after infection with resting and activated
macrophages, respectively (Figure 3.18A). We repeated the experiments mentioned
above, but inoculated the macrophages with Hc yeasts at an MOI of 1:10 and 1:50,
respectively. At an MOI of 1:10, 64% of DDR48 (+) yeasts were recovered from resting
macrophages; whereas, 28% of DDR48 (+) yeasts were recovered from activated
macrophages. As expected, survival was considerably reduced in ddr48 yeasts, with
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36% and 7% survival in resting and activated macrophages, respectively. The
complemented ddr48 + DDR48 yeast’s survival levels were near identical to DDR48
(+)’s with 60% and 24% survival in resting and activated macrophages, respectively
(Figure 3.18B). At an MOI of 1:50, 63% and 54% of DDR48 (+) yeasts were recovered
after infection with resting and activated macrophages, respectively. Only 26% and 19%
of ddr48 yeasts were recovered; whereas, 41% and 41% of ddr48 + DDR48 yeasts
were recovered from resting and activated macrophages, respectively (Figure 3.18C).
To ensure that the decrease in Hc recovery in ddr48 yeasts is due to decreased
survival within macrophages and not simply the result of different rates of phagocytosis,
we determined if the same amount of Hc yeasts were being phagocytized between each
strain as well as if the average number of macrophages taking up Hc yeasts was equal
between the Hc strains being tested. To determine the average number of Hc yeasts being
phagocytosed per macrophage, we performed a phagocytic index. We found no
significant difference in the phagocytic index of DDR48 (+) yeasts, ddr48 yeasts, or
ddr48 + DDR48 yeasts, with phagocytic index values being 3.96 yeasts/macrophage,
3.94 yeasts/macrophage, and 4.12 yeasts/macrophage, respectively (Figure 3.19A).
There was no significant difference in the number of macrophages actively phagocytizing
Hc between DDR48 (+) yeasts, ddr48 yeasts, or ddr48 + DDR48 yeasts since
phagocytosis rates were 80.8%, 80.4%, and 80.8%, respectively (Figure 3.19B). These
results show that the decrease in recovery of ddr48 yeasts is due to a decreased fitness
of ddr48 yeasts within macrophages and not due to an entry defect. This suggests that
DDR48 is involved in pathogenesis of Histoplasma yeasts.
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Figure 3.17

Figure 3.17 Hc in Macrophages Gene Expression
Gene expression analysis of HcDDR48 after infection with murine macrophages. qRTPCRs were performed on DDR48 (+) yeasts under optimal growth conditions (control), 4
hours post-infection, and 24 hours post-infection. Histone H3 was used as a normalizer
gene utilizing the ΔΔct method to normalize mRNA levels to the no paraquat control
(dashed line). All data generated were performed on three technical replicates and at least
two biological replicates. Data is graphed as mean  standard error of the mean (SEM).
Statistical analysis were performed using a 1-way ANOVA.
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Figure 3.18

Figure 3.18 Survival within Macrophages
Infection of DDR48 (+),ddr48, and ddr48 + DDR48 yeasts with resting and activated
murine macrophages. Data is graphed as mean  standard error of the mean (SEM).
Statistical analysis were performed using a 2-way ANOVA followed by Tukey’s multiple
comparisons test.
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Figure 3.19

Figure 3.19 Phagocytic Index & Phagocytosis Rate
Determination of phagocytic index (A) and phagocytosis rate (B) for DDR48 (+),
ddr48, and ddr48 + DDR48 yeasts using resting murine macrophages. Data is graphed
as mean  standard error of the mean (SEM). Statistical analysis were performed using a
1-way ANOVA.
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3.6 Loss Of DDR48 Increases Sensitivity Of Histoplasma Yeasts To The Antifungal
Drugs Amphotericin B And Ketoconazole
To determine if HcDDR48 transcription levels are responsive to antifungal drug
exposure, we performed gene expression analysis on DDR48 (+) yeasts before and after
exposure to amphotericin b and ketoconazole, respectively. Amphotericin b exerts its
antifungal effects by binding to fungal sterols, specifically ergosterol, and damaging
fungal membranes (101, 102). Ketoconazole exerts its antifungal activity by interfering
with ergosterol biosynthesis, specifically by inhibition of the enzyme cytochrome P450
14-demethylase (Erg11) (103, 104). The ergosterol synthesis pathway can be seen in
Appendix B. We found that HcDDR48 mRNA levels increased by 3-fold 15 minutes
after the addition of amphotericin b to the growth media. HcDDR48 transcription levels
were 3.6-fold higher than no treatment controls 30 minutes after treatment. HcDDR48
expression levels were 3.5-fold at 60 minutes and 4.3-fold at 120 minutes postamphotericin b exposure (Figure 3.20A). These results demonstrate that HcDDR48 is
responsive to amphotericin b exposure at the transcriptional level. We performed the
same gene expression analysis above on DDR48 (+) yeasts, except we exposed them to
the antifungal drug ketoconazole. We determined that HcDDR48 mRNA levels were
responsive to ketoconazole treatment as well, with HcDDR48 mRNA levels increasing by
5.4-fold 15 minutes after ketoconazole was added to the growth media. Moreover,
HcDDR48 transcript levels continued to be elevated at 6.1-fold, 5.3-fold, and 4.7-fold, 30
minutes, 60 minutes, and 120 minutes, after ketoconazole exposure, respectively (Figure
3.20B).
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To determine if HcDDR48 is involved in Histoplasma’s resistance to antifungal
compounds, we performed a microtiter plate assay to determine the concentrations for
minimum inhibitory concentration (MIC) and 50% inhibition (IC50) of amphotericin b
and ketoconazole against DDR48 (+) yeasts, ddr48 yeasts, and ddr48 + DDR48
yeasts, respectively. Optical density (600 nm) measurements were used to determine Hc
yeast growth over a range of concentrations of either amphotericin b or ketoconazole in
triplicate cultures. MICs were defined as the drug concentration of which no turbidity
(growth) was observed. IC50 values were determined by linear regression of a doseresponse curve constructed for each antifungal drug. DDR48 (+) cells exposed to various
concentrations of amphotericin b showed an IC50 of 0.24  0.035 g/ml (mean  standard
deviation [SD]) and an MIC of 1.5 g/ml. ddr48 cells treated with amphotericin b had
an IC50 of 0.06  0.039 g/ml (mean  standard deviation [SD]) and an MIC of 0.5
g/ml. ddr48 + DDR48 cells showed an IC50 of 0.18  0.040 g/ml (mean  standard
deviation [SD]) and an MIC of 1.4 g/ml. The IC50 and MIC values of ddr48 cells was
decreased by 75% and 67%, respectively, as compared to the values observed in DDR48
(+) cells (Figure 3.21A). These results demonstrate that the loss of HcDDR48 leads to
increased sensitivity of Histoplasma yeasts to the antifungal compound amphotericin b.
We performed the same drug sensitivity assay above with ketoconazole. DDR48 (+) cells
treated with ketoconazole had an IC50 of 1.56  0.123 g/ml (mean  standard deviation
[SD]) and an MIC of 4.0 g/ml. Ketoconazole treated ddr48 cells had an IC50 of 0.48 
0.030 g/ml (mean  standard deviation [SD]) and an MIC of 2.0 g/ml. Moreover,
ddr48 + DDR48 cells treated with ketoconazole had an IC50 of 1.49  0.242 g/ml
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Figure 3.20

Figure 3.20 Antifungal Gene Expression
qRT-PCRs were performed on mold and yeast-phase wild-type (DDR48 (+)) cells under
optimal conditions (control) and 0.25 hour, 0.5 hour, 1 hour, and 2 hours after the
addition of amphotericin B (A) or ketoconazole (B). Histone H3 was used as a normalizer
gene utilizing the ΔΔct method to normalize mRNA levels to the no paraquat control
(dashed line). All data generated were performed on three technical replicates and at least
two biological replicates. Data is graphed as mean  standard error of the mean (SEM).
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(mean  standard deviation [SD]) and an MIC of 4.0 g/ml. We observed a 69%
decrease of the IC50 and 50% decrease of the MIC in ddr48 cells when compared to
DDR48 (+) cells (Figure 3.21B). These results demonstrate that the loss of HcDDR48
also decreases the resistance of Histoplasma yeasts against ketoconazole.
Since amphotericin b and ketoconazole affect different parts of the ergosterol
biosynthesis pathway, we performed gene expression analysis, using qRT-PCR, on
various components of the ergosterol biosynthesis pathway in DDR48 (+) yeasts, ddr48
yeasts, and ddr48 + DDR48 yeasts under optimal growth conditions (HMM) and after
treatment with amphotericin b (HMM + AmB). In optimal conditions, there were no
significant changes in gene expression of HcSrb1, HcErg2, HcErg3, HcErg4, HcErg5,
HcErg7, HcErg25, or HcErg26 in ddr48 yeasts, compared to DDR48 (+) transcript
levels (Figure 3.22 A-G,K,L). In contrast, mRNA levels of HcErg6 and HcErg24 were
decreased by 2-fold and 9.7-fold, respectively, in ddr48 yeasts (Figure 3.22 F,J).
Furthermore, mRNA levels of HcErg11a and HcErg11b were increased by 3.7-fold and
10-fold, respectively, in ddr48 yeasts (Figure 3.22 H,I). These results demonstrate that
the loss of HcDDR48 leads to altered gene expression of constituents of the ergosterol
biosynthesis pathway in optimal growth conditions. Next, we performed gene expression
analysis, using qRT-PCR, to compare transcript levels of the ergosterol pathway genes
mentioned above at either 15, 30, 60, or 120 minutes after treatment with amphotericin b.
In DDR48 (+) yeasts, HcSrb1 mRNA levels increase by 6.6-fold, 6.9-fold, 6.6-fold, and
7.7-fold, respectively, 15 minutes, 30 minutes, 60 minutes, and 120 minutes, respectively,
after treatment of with amphotericin b. In ddr48 cells treated with amphotericin b,
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HcSrb1 mRNA levels increase by 2.8-fold, 3.0-fold, 3.9-fold, and 2.9-fold, respectively,
15 minutes, 30 minutes, 60 minutes, and 120 minutes, respectively, (Figure 3.23) after
treatment with amphotericin b, which is significantly decreased by 58%, 57%, 41%, and
62%, respectively, as compared to DDR48 (+) expression levels. There were no
differences in transcriptional regulation of HcErg2 between DDR48 (+) yeasts and
ddr48 yeasts, as mRNA levels increased by 2.4-fold 15 minutes after treatment with
amphotericin b in both Hc strains and remained at that level throughout the course of the
experiment (Figure 3.23). HcErg3 mRNA levels increased by 6.7-fold within 15 minutes
after treatment of DDR48 (+) yeasts with amphotericin b, and remained upregulated by
8.6-fold, 9.7-fold, and 13.2-fold, at 30, 60, and 120 minutes, respectively, post-treatment.
In contrast, there were no significant changes in HcErg3 mRNA levels in ddr48 yeasts
after amphotericin b treatment, with relative gene expression measured as 1.8-fold, 1.5fold, 1.0-fold, and 1.3-fold, at 15, 30, 60, and 120 minutes, respectively, after treatment.
HcErg4 mRNA levels increase by 2.9-fold, 5.4-fold, 4.1-fold, and 5.4-fold at 15, 30, 60,
and 120 minutes, respectively, in DDR48 (+) yeasts; however, are not altered in ddr48
yeasts (0.9-fold, 0.8-fold, 0.8-fold, and 0.7-fold) throughout the course of the experiment.
The same pattern seen above in HcErg3 and HcErg4 are observed in HcErg5, HcErg6,
HcErg7, HcErg24, and HcErg26 after treatment with amphotericin b, where mRNA
levels of each gene are upregulated in DDR48 (+) cells but remain unchanged in ddr48
cells . In brief, HcErg5 mRNA levels increase by 4.5-fold, 8.0-fold, 8.4-fold, and 10.2fold 15, 30, 60, and 120 minutes, respectively, in DDR48 (+) yeasts after treatment;
whereas, remain at basal levels in ddr48 yeasts (1.8-fold, 1.7-fold, 1.6-fold, and 1.5fold). HcErg6 mRNA levels increase by 9.668

Figure 3.21

Figure 3.21 Dose-Response Curves
Dose-response curves for amphotericin b (A) or ketoconazole (B) using DDR48 (+),
ddr48, and ddr48 + DDR48 yeasts. IC50 values were determined by non-linear
regression and MIC values were determined by which drug concentration yielded no Hc
growth. IC50 and MIC values are represented as mean  standard error of the mean
(SEM). Statistical analysis were performed using a 1-way ANOVA.
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Figure 3.22

Figure 3.22 Ergosterol Pathway Gene Expression
qRT-PCRs were performed on DDR48 (+),ddr48, and ddr48 + DDR48 yeasts under
optimal conditions (HMM). Histone H3 was used as a normalizer gene utilizing the ΔΔct
method to normalize mRNA levels to DDR48 (+) levels (dashed line). All data generated
were performed on three technical replicates and at least two biological replicates. Data is
graphed as mean  standard error of the mean (SEM). Statistical analysis were performed
using a 1-way ANOVA.
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Figure 3.23

Figure 3.23 Ergosterol Pathway Gene Expression with Amphotericin B
Heat map depicting qRT-PCRs performed on mold and yeast-phase wild-type (DDR48
(+)) cells under optimal conditions (control) and 0.25 hour, 0.5 hour, 1 hour, and 2 hours
after the addition of amphotericin b (A) or ketoconazole (B). Histone H3 was used as a
normalizer gene utilizing the ΔΔct method to normalize mRNA levels to the no treatment
control (dashed line). All data generated were performed on three technical replicates and
at least two biological replicates. Data is graphed as mean  standard error of the mean
(SEM).
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fold, 9.2-fold, 9.2-fold, and 13.1-fold 15, 30, 60, and 120 minutes, respectively, in
DDR48 (+) yeasts after treatment; whereas, remain at basal levels in ddr48 yeasts (1.4fold, 1.5-fold, 1.7-fold, and 1.7-fold) . HcErg7 mRNA levels increase by 2.8-fold, 4.1fold, 3.4-fold, and 5.2-fold 15, 30, 60, and 120 minutes, respectively, in DDR48 (+)
yeasts after treatment; whereas, remain at basal levels in ddr48 yeasts (0.8-fold, 0.9fold, 1.2-fold, and 1.1-fold). HcErg24 mRNA levels increase by 6.9-fold, 9.5-fold, 11.0fold, and 6.3-fold 15, 30, 60, and 120 minutes, respectively, in DDR48 (+) yeasts after
treatment; whereas, remain at basal levels in ddr48 yeasts (1.9 -fold, 1.6-fold, 1.5-fold,
and 1.4-fold). HcErg26 mRNA levels increase by 5.4-fold, 9.2-fold, 7.1-fold, and 6.1fold 15, 30, 60, and 120 minutes, respectively, in DDR48 (+) yeasts after treatment;
whereas, remain at basal levels in ddr48 yeasts (1.3-fold, 1.2-fold, 1.0-fold, and 1.4fold) (Figure 3.23). These results demonstrate that HcDDR48 positively regulates gene
expression of a subset of ergosterol biosynthesis genes in response to treatment with
amphotericin b. In contrast, after treatment with amphotericin b, HcERg11a mRNA
levels are significantly higher in ddr48 yeasts as compared to wild-type DDR48 (+)
mRNA levels. In DDR48 (+) yeasts, HcErg11a transcription levels increase by 3.2-fold,
3.8-fold, 3.8-fold, and 6.0-fold after 15, 30, 60, and 120 minutes, respectively, posttreatment; whereas, in ddr48 yeasts, HcErg11a transcription levels increase by 8.4fold, 7.3-fold, 12.5-fold, and 12.7-fold after 15, 30, 60, and 120 minutes, respectively,
post-treatment. Furthermore, HcErg11a mRNA levels are 8.9-fold, 7.2-fold, 12.4-fold,
and 10.4-fold higher after 15, 30, 60, and 120 minutes, respectively, in ddr48 yeasts as
compared to DDR48 (+) levels after treatment with amphotericin b (Figure). The results
seen regarding HcErg11a transcriptional regulation suggest that HcDDR48 negatively
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regulates HcErg11a mRNA levels in in both optimal growth conditions (HMM) and in
response to treatment with amphotericin b. Upon performing transcript level analysis of
HcErg11b in DDR48 (+) yeasts after amphotericin b treatment, we found that HcErg11b
mRNA levels increase by 30.1-fold, 23.3-fold, 22.9-fold, and 27.7-fold after 15, 30, 60,
and 120 minutes, respectively, post-treatment; whereas, in ddr48 yeasts, HcErg11b
transcription levels increase by 11.3-fold, 6.3-fold, 8.3-fold, and 8.6-fold after 15, 30, 60,
and 120 minutes, respectively, post-treatment. HcErg11b transcriptional response to
amphotericin b is dampened in ddr48 yeasts by 62%, 73% 64%, and 69%, respectively.
In DDR48 (+) yeasts, HcErg25 transcription levels increase by 12.7-fold, 15.4-fold, 10.0fold, and 13.3-fold after 15, 30, 60, and 120 minutes, respectively, post-treatment;
whereas, in ddr48 yeasts, HcErg25 transcription levels increase by 4.9-fold, 4.6-fold,
5.5-fold, and 6.1-fold after 15, 30, 60, and 120 minutes, respectively, post-treatment
(Figure 3.23). These results demonstrate that HcErg25’s transcriptional response to
amphotericin b treatment is dampened by 61%, 70%, 45%, and 54%, respectively, in
ddr48 yeasts, as compared to DDR48 (+) levels. The compilation of the results
presented above demonstrates that DDR48 aids in the response and adaptation of
Histoplasma yeasts against amphotericin B by modulating transcription of ergosterol
biosynthesis genes.
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CHAPTER IV – DISCUSSION & FUTURE DIRECTIONS
4.1 The Histoplasma capsulatum DDR48 Gene
In this study, we aimed to increase our understanding of the DDR48 gene in
Histoplasma capsulatum and determine if DDR48 is essential for response to oxidative
stress, response to antifungal drugs, and survival within phagocytes. We employed a
bioinformatics analysis and identified nine repeats of the amino acid sequence
SNN(N/D)DSYG within the Histoplasma DDR48 amino acid sequence, which is
consistent with sequences of DDR48 from the well characterized fungi S. cerevisiae and
C. albicans. In an attempt to determine the function of DDR48 in Histoplasma, we
analyzed the amino acid sequence for conserved domains using NCBI’s Domain
Architecture Retrieval Tool (DART) and found that the Histoplasma DDR48 amino acid
sequence contains conserved domains most closely related to a group of ATP-dependent
RNA helicases (PTZ00110). This group of RNA helicases use ATP molecules to achieve
their RNA un-winding activities hence they also exhibit ATP hydrolysis (105). A study
on DDR48 in S. cerevisiae concluded that DDR48 possesses ATP and GTP hydrolysis
abilities (24). This part of the study is purely theoretical modeling and algorithms;
therefore, more direct analysis of DDR48’s function would need to be completed before
we can determine if DDR48 has RNA binding capabilities.
Most genes that are enriched in one growth phase of Histoplasma are essential for
survival or pathogenesis. For example, the extracellular superoxide dismutase SOD3 is
only expressed in yeast-phase Histoplasma as extracellular oxidative stress defense is
most likely to be needed when phagocytes undergo oxidative bursts as an effort to
eliminate Histoplasma yeasts in vivo (20). If the gene in question is essential for
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maintaining a specific morphotype (mold or yeast), then the absence of the gene results in
Histoplasma cells that are “locked” in one phase of growth, independent of temperature
or transcriptional growth programs. An example would be the Histoplasma MSB2 gene,
which was found to be essential for formation of hyphae, as deletion of MSB2 resulted in
the cells being yeast-locked, where Histoplasma grew as yeasts at room temperature as
well as 37C (106).We have shown that Histoplasma DDR48 is enriched in the moldphase of growth in optimal conditions, which suggests that DDR48 has an essential role
that is specific to the mold-phase of growth. We showed this was not the case with
DDR48, as mold-phase growth of the ddr48 mutant was phenotypically no different
than DDR48-expressing strains, where both grew as hyphae at room temperature and
yeasts at 37C. Even though DDR48 expression is enriched in mold-phase in optimal
conditions, our gene expression studies of DDR48 showed that it’s expression increased
in response to oxidative stress in Histoplasma yeasts. We have shown that DDR48 is
constitutively expressed in mold-phase Histoplasma and inducible in Histoplasma yeasts.
This brings up many questions regarding the study of phase-specific genes in dimorphic
fungi. In past studies, if a gene was found to only be transcribed in one growth phase it
was labelled as a phase-specific gene. Here we show that much more care should be
taken when characterizing potential phase-specific genes. The higher basal transcription
rate of DDR48 in Histoplasma mold could be attributed to an increased exposure to
oxidative stress as compared to Histoplasma yeasts, although this is just speculation.
Pathogenic phase Histoplasma yeasts are in a controlled environment within the host,
where exogenous oxidative stress is expected, thus the production of the secreted SOD3
superoxide dismutase. Environmental conditions encountered by Histoplasma mold are
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variable and dependent upon geographic location, nutrient availability, and weather
conditions (107–110). By having DDR48 constitutively expressed in mold-phase
Histoplasma, the fungi may be better poised to deal with the unpredictable environments
it will encounter, though more studies would be needed in order to support this concept.
4.2 Oxidative Stress Response
Growth of the ddr48 strain was severely inhibited by the presence of oxidative
stress generators, demonstrating that DDR48 is required for response to oxidative stress
in Histoplasma yeasts. Complementation of the ddr48 mutant with an episomal copy of
DDR48 fully rescued resistance to oxidative stress to levels seen in the wildtype strain.
We have also shown through our gene expression data that transcription of DDR48
mRNAs is responsive to the presence of oxidative stress. An up-regulation of DDR48
mRNAs was seen within 15 minutes after exposure of Histoplasma yeasts to oxidative
stress. Maximum DDR48 expression is achieved 30 minutes after oxidative stress
exposure, thereafter mRNA levels returned to baseline. These results are consistent with
experiments performed in S. cerevisiae and C. albicans that determined DDR48 is
involved in the oxidative stress response (24, 82, 111–114). The cytosolic superoxide
dismutase SOD1 and the cytosolic catalase CatP are responsible for detoxification of
intracellular ROS in Histoplasma yeasts (20, 78). Gene expression of SOD1 and CatP
increases when there is an increase in intracellular ROS to rapidly eliminate them, as
demonstrated in this dissertation. Interestingly, gene expression of both SOD1 and CatP
was significantly decreased in the ddr48 strain in liquid HMM cultures, even without
oxidative stress. While SOD1 gene expression was decreased in ddr48 yeasts, when
challenged with the ROS generator paraquat, SOD1 mRNA levels still increased but not
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to the same magnitude of wildtype Histoplasma yeasts. This suggests that DDR48 is
involved in basal regulation of SOD1 transcription and not necessarily in its regulation in
response to oxidative stress. On the other hand, CatP gene expression in ddr48 yeasts
was not responsive to an increase in ROS, suggesting that DDR48 is involved in
modulating CatP in response to oxidative stress in addition to basal regulation of
transcription. These findings suggest that DDR48-dependent modulation is different for
each gene. We confirmed these results on the enzymatic level and determined that
catalase and superoxide dismutase enzymatic activities were decreased in ddr48 cells
and activity was rescued in the DDR48 complementation strain, consistent with our
transcription data. We conclude that DDR48 directly or indirectly modulates intracellular
catalase and superoxide dismutase activity since the lack of DDR48 leads to a decrease in
growth when exposed to oxidative stress. It is important to mention that DDR48 is not
required for detoxification of ROS generated by basal cellular metabolism, as deficits in
growth are only seen when subjected to stress; although, this lack of phenotype could be
as a result of other compensatory pathways that is sufficient enough to rescue growth
under optimal conditions.
Though cytosolic ROS detoxification machinery is dysregulated in ddr48 yeasts,
the glutathione-dependent ROS detoxification machinery compensates. When ddr48
yeasts were challenged with ROS, the cytosolic thioredoxin reductase TRR1, the
cytosolic thioredoxin TRX1, the glutamate-cysteine ligase GSH1, and the glutathione
synthetase GSH2, were all transcriptionally up-regulated; whereas, when Histoplasma
yeasts containing a functional copy of DDR48 are challenged with ROS, there are no
observable changes in gene expression of the glutathione-dependent transcripts GSH1,
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GSH2, TRR1, and TRX1. These results demonstrate that one way Histoplasma yeasts
compensate for the loss of DDR48 is by activating alternative ROS detoxification
pathways to aid in survival. These results are consistent with studies in S. cerevisiae
where yeasts lacking the cytosolic thioredoxin system were more susceptible to killing by
oxidative stress (115). To further examine the glutathione-dependent compensation, we
will perform a glutathione assay on lysates from wild-type and ddr48 yeasts to
quantitate the glutathione levels. We will also determine the amount of oxidative stress in
wild-type and ddr48 yeasts with and without the addition of paraquat by using the
fluorogenic dye DCFDA that measures reactive oxygen species within cells. To
accomplish ROS measurement, we will incubate Histoplasma yeasts in the presence of
DCFDA in a 96-well tissue culture plate for 1 hour. Following incubation, we will lyse
the yeasts by the addition of DMSO and then quantitate the amount of DCFDA
fluorescence using a microplate reader.
4.3 H. capsulatum Survival in Macrophages
We also demonstrated the need for a functional copy of DDR48 for Histoplasma
yeasts to survive within resting and activated macrophages. We have shown that
Histoplasma survival is consistently decreased by half in ddr48 yeasts at multiple
Histoplasma doses. This could be due to the increased oxidative stress that Histoplasma
encounters within phagocytes or that there is less entry of ddr48 yeasts into phagocytic
cells. We demonstrated that the decrease in survival is not due to an entry defect as the
same phagocytosis rates were observed in DDR48-expressing strains and mutant strains.
When infected with fungal pathogens, phagocytes initiate an oxidative burst via the
NADPH oxidase system that serves to control fungal growth (116). Histoplasma yeasts
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do contain an extracellular catalase, CatB, and an extracellular superoxide dismutase,
SOD3, to counter the ROS derived from phagocytes. CatB gene expression was not
altered by the loss of DDR48, suggesting that the decreased survival is not directly due to
less extracellular catalase activity. Since endogenous ROS is increased by the decreased
cytosolic catalase and superoxide dismutase activity in ddr48 yeasts, the extracellular
ROS detoxification machinery could be compensating for this loss and indirectly leading
to more effective killing of Histoplasma within phagocytes.
In these experiments, we used RAW 264.7 macrophage-like cells. To obtain data
that is more directed towards its potential therapeutic value, we will perform these
survival experiments using murine bone-marrow derived macrophages (BMDMs) by
isolating bone marrow from wildtype mice and stimulating macrophage differentiation by
activation with GM-CSF. We will also perform these survival assays on macrophages
derived from human blood by obtaining blood samples from healthy volunteers and
obtaining the white blood cell (WBC) fraction. To determine if we observe the same
deficiency in ddr48 yeasts in vitro, we will utilize the murine model of Histoplasmosis
to perform an in vivo analysis. We will inoculate healthy, wildtype mice with 2 x106
Histoplasma yeasts that are wildtype or the ddr48 strain. At day 3 and day 7 postinfection, we will euthanize mice and dissect lungs and spleens. The organs will then be
homogenized and dilutions spread onto HMM plates. Once the HMM plates have
incubated for 7-14 days, we will count the number of Histoplasma yeasts recovered and
determine fungal burden for each sample.
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4.4 Antifungal Compounds and The Ergosterol Biosynthesis Pathway
The antifungals fluconazole and itraconazole, in combination with amphotericin
B, are mainline treatments for infection with Histoplasma capsulatum (117). One of the
leading causes of treatment failure in HIV-positive patients with H. capsulatum infections
is resistance to azole antifungals, thus new treatment options are needed to decrease
relapse prevalence (118). Here we have shown that DDR48 aids in proliferation of
Histoplasma yeasts when exposed to ketoconazole and amphotericin B, as inhibitory
concentrations decrease in the ddr48 strain. These results are consistent with studies in
C. albicans where researchers found that fluconazole-resistant isolates of C. albicans
from patients had higher expression levels of DDR48. They also found a high correlation
of DDR48 and azole resistant genes, suggesting DDR48 is a candidate for potentially
novel antifungal therapies (22). One way DDDR48 seems to exert its protective effects is
by modulating the ergosterol biosynthesis pathway, which is consistent with studies in C.
albicans where a gain of function mutation leading to increased expression of ergosterol
biosynthesis genes led to an increase in antifungal drug resistance (119). Expounding
upon these studies, we will perform an in vivo experiment where mice will be inoculated
with either wildtype or ddr48 yeasts with or without intervention with antifungal
therapy. On day 3 post-infection, half of the mice within each group will receive a dose
of either amphotericin B or fluconazole. We will monitor the course of infection until day
7 when mice will be euthanized. Lungs and spleens will be harvested from each animal
and fungal burden determined. While our data indicated that the loss of DDR48 increased
sensitivity to amphotericin B and ketoconazole, we should also investigate the effects of
the ddr48 mutant with other common antifungals.
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4.5 Theoretical Function of DDR48
This dissertation has demonstrated that DDR48 functions in various pathways in
H. capsulatum to aid in fungal stress response and proliferation. We have shown that
DDR48 is involved in the oxidative stress response and that the loss of DDR48 leads to
increased sensitivity of Histoplasma yeasts to ROS. DDR48 appears to modulate the
transcription of SOD1 and CatP, a cytosolic superoxide dismutase and catalase,
respectively. We also demonstrated that DDR48 is essential for survival of Histoplasma
yeasts within resting and activating murine macrophages, suggesting it is required for
pathogenesis. In vivo research will need to be conducted before we can conclude that
DDR48 is needed pathogenesis as in vitro data does not always correlate to an in vivo
system, where the host immune system is involved (120, 121). We also concluded that
the loss of DDR48 led to increased sensitivity of Histoplasma yeasts to amphotericin B
and ketoconazole, suggesting that DDR48 could be exploited as a potential therapeutic
target. All of these results taken together point to DDR48 possessing a central role in
modulating the fungal cellular stress response. We cannot exclude the possibility that
DDR48 is a global modulator of cellular stress response and therefore any stress
encountered by the ddr48 strain will result in a difference in growth compared to
wildtype Histoplasma yeasts. To fully understand which genes are DDR48-dependent for
their proper modulation, we will employ a transcriptome-wide analysis using highthroughput RNA sequencing. We will first grow triplicate cultures of wildtype, ddr48
yeasts, and complemented yeasts to mid-log followed by RNA extractions. RNA extracts
will be cleaned up through an RNA column to remove any contaminating materials and
subjected to DNAse treatment to remove any genomic DNA carried over during the
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experiment. We will then analyze the fidelity of the RNA by running the samples through
a bio-analyzer followed by RNAseq analysis. The results will show which transcripts are
modulated in a DDR48-dependent manner.
We hypothesize that DDR48 possesses endogenous RNA binding capabilities and
acts as a cytoplasmic RNA binding protein. To determine if DDR48 binds RNAs in
physiological conditions we will employ a transcriptome-wide screen using CLIP-Seq, a
technique that consists of UV cross-linking, immunoprecipitation, and high throughput
sequencing (122, 123). To start, we would growth cultures of Histoplasma yeasts in
Histoplasma macrophage medium with or without paraquat to stimulate oxidative stress.
We would allow the cultures to incubate for 1 hour before UV-crosslinking, which
crosslinks all of the RNA/protein complexes that were associated together at that moment
in time. After crosslinking, we will select specifically for DDR48/RNA complexes by
incubating the crosslinked lysate with magnetic beads containing a DDR48-specific
antibody. Once captured, the complexes will be de-crosslinked and RNAs separated for
analysis. The captured RNAs will then be sent for deep-sequencing analysis to determine
which, if any, RNAs DDR48 is able to bind. Interestingly, Jin and associates identified
DDR48 as a component of processing bodies (P-bodies) and glycolytic bodies (G-bodies)
in C. albicans (124). P-bodies are mRNA granules whose function is in maintaining the
balance between translating mRNAs and mRNA degradation. P-bodies contain
aggregates of mRNA decay machinery and mRNAs destined for repression/degradation
or balanced reentry into translation (125). In response to cellular stress, such as glucose
starvation, stress granules are formed from P-bodies to aid in response and recovery from
the stress (125–127). Each of these mRNA granules relies upon RNA binding proteins for
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proper structure and function (128, 129). Mechanisms by which DDR48 could potentially
be participating in formation and processing within these specialized non-membrane
bound organelles could be by 1) chaperoning mRNAs into the bodies or 2) serving as a
linker between RNAs within the P-body. We have constructed a
Figure 4.1

Stress

ATP

DDR48

AAA 3’

DDR48 binds to stalled/damaged mRNA

5’

Stalled translation of mRNAs
& mRNA damage due to stress

DDR48
AAA 3’
5’

DDR48

1

AAA 3’
5’
5’

DDR48 chaperones stalled/damaged
mRNA to stress granule for
degradation or timely return to
translation

DDR48
AA

A3

’

2

5’

DDR48

DDR48 binds to mRNAs in stress
granules and serves as a linker
between mRNAs and the stress
granule machinery

DDR48
AA

A3

AAA 3’

D DR48

5’

functional
ribosome

stalled
ribosome

mRNA

nascent
polypeptide

DDR48
protein

stress
granule

’
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Hypothetical pathway depicting possible functions of DDR48 in RNA binding in
response to cellular stress.
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hypothetical model to illustrate these possible functions of DDR48, which can be seen in
Figure 4.1. To determine if DDR48 is involved in mRNA granule formation or function,
we will assess whether DDR48p co-localizes with stress granules when under stress. We
will first construct a Histoplasma strain in which DDR48 has been fused to the green
fluorescence protein (GFP) and the RNA binding protein FUS fused with red
fluorescence protein (RFP). We will then take wildtype Histoplasma yeasts and subject
half of the culture to oxidative stress for 1 hour before fixing samples of each condition
onto poly-L-lysine coverslips and mounting onto glass slides. We will then analyze the
localization of each marker using a confocal microscope with fluorescent capabilities to
determine if the two marker co-localize.
We have demonstrated that H. capsulatum relies on DDR48 to adapt and recover
in response to cellular stress and confirmed that it is needed for optimal survival in
macrophages, response to oxidative stress, and response to antifungal drugs. More
research into the function of DDR48 will no doubt uncover more ways in which it is
responsible for survival against cellular stressors in fungal pathogens. Given the broad
range of processes that are dependent upon DDR48, thought should be given to
determining if it could be a successful therapeutic target for those predisposed or
suffering from endemic fungal pathogens, as a pathogen that is not poised to adapt when
exposed to various cellular stressors could tip the balance in favor of the host’s immune
system and eventual elimination of the fungal pathogen.
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APPENDIX A – Quantitative Real-Time PCR Primer Table
Table A1
Gene Name

Forward Primer
(5’ – 3’)

Reverse Primer
(5’ – 3’)

CatA (XP_001539642)

CCTCCCTATTATCCATCGATTTG

ACTGTATCGAAACTGCCTTTG

CatB (XP_001537269)

CGGTGCTGGACAAATGTT

AGACCGTGAGTGAGTTGTA

CatP (XP_001536955)

CCAACTTACACTGACTCCAATG

ATGGTGGTGATATCGCTGA

Ddr48 (XP_001539717)

GACAATACTACCACCTATGGGTCTAA

CTTATCAGCGATGGTTTCCTTCTG

*Erg2 (XP_001544104)

TTCAGCAACCACGGAAAC

CGCCATGCAGTATCGTAAA

*Erg3 (XP_001539283)

GGATTATGCCAAGCCCTTAC

CAGGACAGTCCAGATGTTAATG

Erg4 ( XP_001544658)

GTACATCGTCTATCTGTTTGTTTAC

GCATATCCATACCACCCATC

Erg5 (XP_001538408)

CCACCATCTTCACCATCTTG

CGACGAACTTGTGGAAGAC

Erg6 (XP_001537255)

CTCTTACGCGACATTACTACAA

CCACAGCCTACATCAAGAAC

Erg7 (XP_001543567)

GGCACCTGTATGAACTACAC

GGAAGCAACCAGAGTTCAG

*Erg11a (XP_001540208)

TTCTTGGAACAAAAGGCAACG

CGAGGTTAGCCCGTATTTGAC

*Erg11b (XP_001540641)

CTATGGAACCGACCCGTATAAG

TCGTTGCCCTTTATGCCTAG

Erg24 (XP_001542568)

CCTTCTACTCTTGTGCTTGATAC

AGTGGTAAGAAAGGTGTTGAAT

*Erg25 (XP_001539418)

GCAATAAAATCCCTAGCCTGAAG

TTTGATAAGTCATAGTCCACGGG

Erg26 (XP_001543211)

TATACAGAGACGAAGGCCCAA

GAGGACGAATGGAGAGGATTTG

Hht1 (XP_001539096)

TGGTAAGGTCCCTCGTAAGC

GGAGTTTGCGGATGAGGAG

Sod1 (XP_001543596)

CTTGTGGCGTCATTGGTATCACCACG

CCTCTCCTTCACAACTAAAGCACAGGTG

*Srb1 (XP_001537796)

GTAGCAGCCGAACAACATCTG

AATGAGACCTTGGGCGATACG

Trr1 (XP_001537597)

GATTACAAGTGCGGGATCTG

CCCATGTTACACATCTATCTTCTC

Trx1 (XP_001543832)

GACTCCATCGTCCAAACCA

GAAGGAGGTGCGGTCTTT

* = primer sequence pulled from (CITATION)

* = primer sequence adapted from (130).

Table A.1 Real-time PCR Primer Table
The table contains sense and anti-sense primers and NCBI reference sequence numbers.
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APPENDIX B – Ergosterol Biosynthesis Pathway
Figure B1

acetyl Co-A

Erg10
Erg13
Erg12
Erg8
Erg19
Erg20

farnesyl pyrophosphate
Erg9
squalene
Erg1
squalene epoxide
Erg7
lanosterol
Erg6
24-methylene lanosterol
ketoconazole

Erg11a / Erg11b
4,4-dimethylergosta-8,14,24(28)-trien-3b-ol
Erg24
4,4-dimethylfecosterol
Erg25 / Erg26 / Erg27
4-methylfecosterol
Erg25 / Erg28 / Erg27
fecosterol
Erg2
episterol
Erg3
ergosta-5,7,24(28)-trien-3b-ol
Erg5
ergosta-5,7,22,24(28)-tetraen-3b-ol
Erg4

amphotericin b

ergosterol

Cell Membrane
oxygen consuming reaction

Table B.1 Ergosterol biosynthesis pathway.
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APPENDIX C – DDR48 Gene Expression In Response To 4NQO and 5FC
4NQO and 5-Fluorocytosine Induce DDR48 Expression in Histoplasma Yeasts
Since DDR48 mRNA levels were responsive to oxidative stress we also asked if
other forms of cellular stress induce DDR48. We performed the same timepointdependent gene expression profiles as previously mentioned using either 4nitroquinoline-1-oxide (4NQO) or 5-fluorocytosine (5FC). 4NQO is a quinoline
derivative that induces DNA lesions that are most always corrected by the nucleotide
excision repair machinery and produces reactive oxygen species; whereas, 5FC is an
antifungal compound that inhibits biosynthesis of both fungal RNA and DNA (131, 132).
We found that both 5FC and 4NQO upregulate expression of DDR48 in Histoplasma
yeasts (Figure C1-A&B).
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Figure C1

Figure C.1 5FC and 4NQO Gene Expression
Gene expression of DDR48 after 5FC or 4NQO exposure. qRT-PCRs were performed on
mold and yeast-phase wild-type (DDR48 (+)) cells under optimal conditions (control)
and 0.25 hour, 0.5 hour, 1 hour, and 2 hours after the addition of 5-fluorocytosine (5FC)
(A) or 4-nitroquinoline-1-oxide (4NQO) (B). Histone H3 was used as a normalizer gene
utilizing the ΔΔct method to normalize mRNA levels to the no paraquat control (dashed
line). All data generated were performed on three technical replicates and at least two
biological replicates. Data is graphed as mean  standard error of the mean (SEM).
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